<SEC-DOCUMENT>0001213900-23-023408.txt : 20230328
<SEC-HEADER>0001213900-23-023408.hdr.sgml : 20230328
<ACCEPTANCE-DATETIME>20230328080013
ACCESSION NUMBER:		0001213900-23-023408
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		18
CONFORMED PERIOD OF REPORT:	20230323
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230328
DATE AS OF CHANGE:		20230328

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			authID Inc.
		CENTRAL INDEX KEY:			0001534154
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-PREPACKAGED SOFTWARE [7372]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40747
		FILM NUMBER:		23766216

	BUSINESS ADDRESS:	
		STREET 1:		1325 S. COLORADO BLVD.
		STREET 2:		BUILDING A, SUITE 322
		CITY:			DENVER
		STATE:			CO
		ZIP:			80222
		BUSINESS PHONE:		516-274-8700

	MAIL ADDRESS:	
		STREET 1:		1624 MARKET ST. STE 226
		STREET 2:		UNIT 51767
		CITY:			DENVER
		STATE:			CO
		ZIP:			80202-1559

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Ipsidy Inc.
		DATE OF NAME CHANGE:	20170206

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ID Global Solutions Corp
		DATE OF NAME CHANGE:	20141014

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	IIM Global Corp
		DATE OF NAME CHANGE:	20130107
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea175837-8k_authid.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:us-gaap-supplement="http://fasb.org/us-gaap-sup/2022q3" xmlns:srt-supplement="http://fasb.org/srt-sup/2022q3" xmlns:us-roles="http://fasb.org/us-roles/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:AUID="http://authid.ai/20230323">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02B_US%2DGAAP%2D2022 -->
<!-- Field: Set; Name: xdx; ID: xdx_03E_AUID_authid.ai_20230323 -->
<!-- Field: Set; Name: xdx; ID: xdx_040_20230323_20230323 -->
<!-- Field: Set; Name: xdx; ID: xdx_056_edei%2D%2DEntityCentralIndexKey_0001534154 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2023-03-23to2023-03-23" name="dei:EntityCentralIndexKey">0001534154</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-03-23to2023-03-23" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="auid-20230323.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2023-03-23to2023-03-23">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001534154</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-23</xbrli:startDate>
        <xbrli:endDate>2023-03-23</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Washington, D.C. 20549</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_908_edei--DocumentType_c20230323__20230323_zQJH1t9LT5w"><ix:nonNumeric contextRef="From2023-03-23to2023-03-23" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PURSUANT TO SECTION 13 OR 15(d) OF</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>THE SECURITIES EXCHANGE ACT OF 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported):
<span id="xdx_901_edei--DocumentPeriodEndDate_c20230323__20230323_zgJXQMGkdtQ9"><ix:nonNumeric contextRef="From2023-03-23to2023-03-23" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">March 23, 2023</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img src="image_001.jpg" alt="" />&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_900_edei--EntityRegistrantName_c20230323__20230323_zquSsR00uGMi"><ix:nonNumeric contextRef="From2023-03-23to2023-03-23" name="dei:EntityRegistrantName">authID Inc.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90C_edei--EntityIncorporationStateCountryCode_c20230323__20230323_z9oz5M77tXf"><ix:nonNumeric contextRef="From2023-03-23to2023-03-23" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_907_edei--EntityFileNumber_c20230323__20230323_z9ZbV4Uo4BK7"><ix:nonNumeric contextRef="From2023-03-23to2023-03-23" name="dei:EntityFileNumber">001-40747</ix:nonNumeric></span></b></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90D_edei--EntityTaxIdentificationNumber_c20230323__20230323_z3iCrSiFQIQb"><ix:nonNumeric contextRef="From2023-03-23to2023-03-23" name="dei:EntityTaxIdentificationNumber">46-2069547</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State or Other Jurisdiction<br />
of Incorporation)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission File Number)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(IRS Employer<br />
Identification Number)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_908_edei--EntityAddressAddressLine1_c20230323__20230323_zFxdmkoe6VTa"><ix:nonNumeric contextRef="From2023-03-23to2023-03-23" name="dei:EntityAddressAddressLine1">1385 S. Colorado Blvd.</ix:nonNumeric></span>, <span id="xdx_906_edei--EntityAddressAddressLine2_c20230323__20230323_z9or3mFVAx33"><ix:nonNumeric contextRef="From2023-03-23to2023-03-23" name="dei:EntityAddressAddressLine2">Building A, Suite 322</ix:nonNumeric></span>,
<span id="xdx_90B_edei--EntityAddressCityOrTown_c20230323__20230323_zRAibWAYoKmi"><ix:nonNumeric contextRef="From2023-03-23to2023-03-23" name="dei:EntityAddressCityOrTown">Denver</ix:nonNumeric></span>, <span id="xdx_904_edei--EntityAddressStateOrProvince_c20230323__20230323_z5IusWvZrlGb"><ix:nonNumeric contextRef="From2023-03-23to2023-03-23" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">Colorado</ix:nonNumeric></span> <span id="xdx_904_edei--EntityAddressPostalZipCode_c20230323__20230323_z2OlYqWmKEoh"><ix:nonNumeric contextRef="From2023-03-23to2023-03-23" name="dei:EntityAddressPostalZipCode">80222</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of principal executive offices) (zip code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_90E_edei--CityAreaCode_c20230323__20230323_zODcWwZKiPP4"><ix:nonNumeric contextRef="From2023-03-23to2023-03-23" name="dei:CityAreaCode">516</ix:nonNumeric></span>-<span id="xdx_908_edei--LocalPhoneNumber_c20230323__20230323_z8W6t4d0Z3p7"><ix:nonNumeric contextRef="From2023-03-23to2023-03-23" name="dei:LocalPhoneNumber">274-8700</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Registrant&#8217;s telephone number, including area
code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General
Instruction A.2. below):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_edei--WrittenCommunications_c20230323__20230323_zgYpKE7IjHW3"><ix:nonNumeric contextRef="From2023-03-23to2023-03-23" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_edei--SolicitingMaterial_c20230323__20230323_zNmNOxNeoIt8"><ix:nonNumeric contextRef="From2023-03-23to2023-03-23" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_edei--PreCommencementTenderOffer_c20230323__20230323_zJjpv1UPN3Hc"><ix:nonNumeric contextRef="From2023-03-23to2023-03-23" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_edei--PreCommencementIssuerTenderOffer_c20230323__20230323_zdsYxA7zNkOa"><ix:nonNumeric contextRef="From2023-03-23to2023-03-23" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section 12(b) of the Act: &#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title of each class</b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading Symbol</b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name of each exchange on which registered</b></span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--Security12bTitle_c20230323__20230323_zpyvVXnYL3pk"><ix:nonNumeric contextRef="From2023-03-23to2023-03-23" name="dei:Security12bTitle">Common Stock par value $0.0001 per share</ix:nonNumeric></span></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_edei--TradingSymbol_c20230323__20230323_z0BUxPBA4mA4"><ix:nonNumeric contextRef="From2023-03-23to2023-03-23" name="dei:TradingSymbol">AUID</ix:nonNumeric></span></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The <span id="xdx_900_edei--SecurityExchangeName_c20230323__20230323_zMa4I8VWlm17"><ix:nonNumeric contextRef="From2023-03-23to2023-03-23" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market, LLC&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Emerging growth Company <span id="xdx_908_edei--EntityEmergingGrowthCompany_c20230323__20230323_z9LZYcigKEd2"><ix:nonNumeric contextRef="From2023-03-23to2023-03-23" format="ixt:booleantrue" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.&#160;<span id="xdx_90D_edei--EntityExTransitionPeriod_c20230323__20230323_zZrxyOl21zij"><ix:nonNumeric contextRef="From2023-03-23to2023-03-23" format="ixt:booleantrue" name="dei:EntityExTransitionPeriod">&#9746;</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify"><b>Item
5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Agreements of Certain
Officers</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 23, 2023, authID Inc. (the &#8220;Company&#8221;)
and Rhoniel A. Daguro, a director of the Company, entered an Offer Letter pursuant to which Mr. Daguro agreed to serve as Chief Executive
Officer of the Company in consideration of an initial annual salary of $400,000. Mr. Daguro will be eligible for an annual target bonus
of up to $375,000 based on performance milestones. For the period ending March 31, 2024, a bonus amount of $75,000 shall be payable upon
the Company achieving increments of $1,000,000 in total contract value of all customer agreements less claw backs (&#8220;Bookings&#8221;)
up to an aggregate of $5,000,000 in Bookings. For subsequent years, Mr. Daguro and the Compensation Committee of the Board will mutually
agree as to the performance targets to earn for the annual bonus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company will provide Mr. Daguro with an initial
grant of options (&#8220;Initial Grant&#8221;) to purchase 2,455,000 shares of common stock for a period of ten years vesting subject
to achievement of performance and service conditions. The exercise price will be the closing price of the common stock on the Nasdaq Stock
Market on the third trading day after the announcement of all pending material non-public information. Upon the Company being able to
grant additional options under a stock incentive plan, it will make an additional grant of options to Mr. Daguro to acquire 1,115,000
shares of common stock for a period of ten years vesting subject to achievement of performance and service conditions (the &#8220;Additional
Grant&#8221;). The exercise price of the options shall be equal to the closing price of the common stock on the Nasdaq Stock Market on
the date of such Additional Grant. If and to the extent that the exercise price under the Additional Grant is higher than the exercise
price under the Initial Grant, the Company shall determine the incremental cost of the Additional Grant by deducting the exercise price
of the Initial Grant from the exercise price of the Additional Grant and multiplying the difference by 1,115,000 (the &#8220;Difference&#8221;).
The Difference shall be payable by the Company to Mr. Daguro as a bonus payable upon exercise of options comprised in the Additional Grant,
by way of offset against the exercise price of such options to the extent of the total exercise price of the options being exercised at
that time. To the extent that the entire Difference cannot be applied to any particular exercise, the balance shall be carried forward
and applied to future exercises of the Additional Grant. In lieu of agreeing to pay the bonus, the Company may in its sole discretion
elect to grant Mr. Daguro an additional 350,000 shares of common stock as part of the Additional Grant (for a total of 1,465,000 shares
of common stock under the Additional Grant).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The employment of Mr. Daguro is at will and may
be terminated at any time, with or without formal cause. The Company also entered an Executive Retention Agreement with Mr. Daguro, pursuant
to which the Company agreed to provide specified severance and bonus amounts and to accelerate the vesting on his equity awards upon termination
upon a change of control or an involuntary termination, as each term is defined in the agreement. &#160;In the event of a termination
upon a change of control or an involuntary termination, Mr. Daguro is entitled to receive an amount equal to 100% of his base salary,
the actual bonus earned but unpaid for the previous year and any bonus that was earned but unpaid prior to the termination date. Further,
upon termination upon a change of control or an involuntary termination, the Company will reimburse Mr. Daguro for the cost of continuation
of health coverage for Mr. Daguro and his eligible dependents pursuant to COBRA until the earlier of 12 months following the termination
date, the date Mr. Daguro and his dependents are eligible for health coverage from a new employer or the date Mr. Daguro and his eligible
dependents are no longer eligible for COBRA.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">Mr. Daguro
has over 20 years of sales, marketing, technology, and venture capital experience. He has built multiple profitable software and professional
services firms. Most recently, from 2018 to 2022, he served as the Chief Revenue Officer of Socure Inc. Prior to that, Mr. Daguro held
various executive sales positions with Persistent Systems, Hortonworks, and Oracle.</span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 23, 2023, the Company and Thomas Thimot
entered into a Confidential Separation Agreement and General Release for the purposes of separation of Mr. Thimot from the Company as
Chief Executive Officer and an employee by mutual consent and settling, compromising and resolving all claims between them. Mr. Thimot&#8217;s
resignation was effective March 23, 2023. In addition to the Company paying all accrued but unpaid salary and providing reimbursement
for all outstanding expenses, the Company has agreed to pay Mr. Thimot $325,000 which shall be deferred until the earlier of April 1,
2025 and a change of control of the Company and is subordinated to the initial advance in the amount of $900,000 made pursuant to the
Amended &amp; Restated Facility Agreement entered into as of March 8, 2023 between the Company and Stephen Garchik, as well as to all
present and future secured indebtedness of the Company under the Senior Convertible Notes issued by the Company as of March 21, 2022 and
pursuant to such Facility Agreement. Mr. Thimot will also be eligible for certain health benefits. The exercise period with respect to
Mr. Thimot&#8217;s stock option to acquire 262,500 shares of common stock at an exercise price of $7.20 per share was extended through
March 23, 2027. All unvested grants or other equity awards lapsed and are no longer exercisable as of the separation date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 9.01 Financial Statements and Exhibits</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit No.</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 89%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">10.1</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p></td>
    <td>&#160;</td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><a href="ea175837ex10-1_authid.htm">Letter Agreement between Rhoniel A. Daguro and authID Inc. dated March&#160;23, 2023</a></p></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>10.2</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="ea175837ex10-2_authid.htm">Executive Retention Agreement between Rhoniel A. Daguro and authID Inc. dated March&#160;23, 2023</a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td>10.3*</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="ea175837ex10-3_authid.htm">Confidential Separation Agreement and General Release between Thomas Thimot and authID Inc. dated March&#160;23, 2023</a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">* Schedules and certain portions of this exhibit have been omitted pursuant
to Item 601(a)(5) of Regulation S-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 2; Options: NewSection -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>authID Inc.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 60%">&#160;</td>
    <td style="width: 5%">&#160;</td>
    <td style="width: 35%">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: March 28, 2023</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ <span>Hang Thi Bich Pham</span></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&#160;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hang Thi Bich Pham</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">2</p>

<!-- Field: Rule-Page --><div style="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><div style="border-top: black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjV0KwjAQhE/QOyx5Fk1TROmjRUWsIkXE12C3EmyzZZP6cyRvaWwRl4VlmflmhBiJNa1MjQznRZHDEZu21h6hwAoZ7QWDI9tsUwi3wKtxnrX1/fsDMwoMBmY6juc6CL31bhyWKchkomYTlYCMU6ngsBPRV8/IVqZE642uQdsSDkwtG/SaX0PCUT/JUvPqq07IzpBNIR7LQX6DkrGCPd31g/jmIM8zEY36icSaqWu/NZ3z1MCyxiZ0uQH9b/QBGFxJSQ== -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ea175837ex10-1_authid.htm
<DESCRIPTION>LETTER AGREEMENT BETWEEN RHONIEL A. DAGURO AND AUTHID INC. DATED MARCH 23, 2023
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 40%"><IMG SRC="ex10-1_001.jpg" ALT=""></TD>
  <TD STYLE="width: 40%">&nbsp;</TD>
  <TD STYLE="text-align: right; width: 20%"><P STYLE="text-align: left; margin-top: 0; margin-bottom: 0"><B>Tom Thimot</B></P>
                         <P STYLE="text-align: left; margin-top: 0; margin-bottom: 0"><I>Chief Executive Officer</I></P>
                         <P STYLE="text-align: left; margin-top: 0; margin-bottom: 0">tomthimot@authid.ai</P></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 5in">March 23, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>PRIVATE AND CONFIDENTIAL</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 27.35pt 0pt 0">Rhoniel A. Daguro</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 27.35pt 0pt 0">846 Farm Drive</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 27.35pt 0pt 0">West Chicago, IL 60185</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>Re: <U>Employment Offer</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dear Rhon:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The management of authID Inc.
(the &quot;<B>Company</B>&quot;) takes pleasure in extending you this offer to join the Company as the Chief Executive Officer reporting
to the Board of Directors of the Company (the &ldquo;<B>Board</B>&rdquo;). As part of your responsibilities, you will be required to provide
services to other subsidiaries and affiliates of the Company (together with the Company, collectively referred to as the (&ldquo;<B>Group</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Your job responsibilities
will comprise managing and overseeing all operations and matters of the Group, in order to establish a successful business and manage
growth. In addition, you will undertake such functions as are customarily applicable to your position, as well as those that are reasonably
assigned to you by the Board. You have been appointed as a member of the Board <FONT STYLE="background-color: white">and you will be nominated
for election and re-election to the Board continuously during </FONT>your employment as Chief Executive Officer of the Company, subject
to any required stockholder approval.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Compensation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Your compensation package
shall consist of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left">(a)</TD><TD STYLE="text-align: justify">Initial base salary of $400,000 per annum, which will be
payable semi-monthly in arrears, and subject to all applicable deductions required by law. Your salary will be reviewed by the Board
from time to time and may thereafter be increased.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left">(b)</TD><TD STYLE="text-align: justify">You will also be eligible for an annual target bonus of up
to $375,000 based on achievement of performance milestones, calculated and payable as follows:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left">(i)</TD><TD STYLE="text-align: justify">For the period ending March 31, 2024 (the &ldquo;Performance
Period&rdquo;) the following performance targets and bonus amounts shall apply:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Milestone</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Bonus Amount</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; text-align: justify; padding-bottom: 1.5pt">$1 million of Bookings</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">75,000</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">$2 million of Bookings</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">75,000</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">$3 million of Bookings</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">75,000</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">$4 million of Bookings</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">75,000</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">$5 million of Bookings</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">75,000</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">authID
Inc. </FONT>&#9679; <FONT STYLE="font-family: Times New Roman, Times, Serif">1385 S. Colorado
Blvd. Building A, Suite 322 </FONT>&#9679; <FONT STYLE="font-family: Times New Roman, Times, Serif">Denver,
CO 80222 </FONT>&#9679; <FONT STYLE="font-family: Times New Roman, Times, Serif">Tel +1 516
274 8700 </FONT>&#9679; <FONT STYLE="font-family: Times New Roman, Times, Serif">www.authid.ai</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 33%"><IMG SRC="ex10-1_002.jpg" ALT="">&nbsp;</TD>
  <TD STYLE="width: 34%">&nbsp;</TD>
  <TD STYLE="width: 33%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Rhoniel A. Daguro</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Page 2</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">March 23, 2023</P>

</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify">The milestones shall be cumulative during
the Performance Period (ie each milestone connotes an additional $1 million of Bookings above the previous milestone). Payment of the
bonus shall be made on the next salary payment date following the determination by the Company that the relevant milestone has been achieved.
In the event of any dispute as to the amount of the Bookings, the matter shall be referred for final determination by the auditors of
the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify">For the purposes of this paragraph:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(1)</TD><TD STYLE="text-align: justify">&ldquo;Bookings&rdquo; shall mean the aggregate of the Total
Contract Value of all Customer Contracts entered into by the Group after the date hereof during the Performance Period.</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.25in"></TD><TD STYLE="width: 0.25in">(2)</TD><TD STYLE="text-align: justify">&ldquo;Claw Back&rdquo; means the net Total Contact Value of any Customer Contract, which is subsequently
terminated by either party without the payment of the full Total Contract Value and in such case the net Total Contract Value, being the
amount to be deducted from Total Contract Value for the purpose of calculating Bookings, shall be equal to the unpaid amount of the Total
Contract Value, which was previously credited to Bookings with respect to such Customer Contract.</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                                                                           </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.25in"></TD><TD STYLE="width: 0.25in">(3)</TD><TD STYLE="text-align: justify">&ldquo;Customer Contract&rdquo; shall mean each new contract, or the renewal of a prior contract with
customers of the Group, for the sale of Verified or other identity products.</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                                                      </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.25in"></TD><TD STYLE="width: 0.25in">(4)</TD><TD STYLE="text-align: justify">&ldquo;Total Contract Value&rdquo; shall mean the higher of (x) the aggregate of the minimum amounts payable
to the Group during the term of each Customer Contract pursuant to the terms of such Customer Contract; and (y) the actual amounts paid
to the Group pursuant to such Customer Contract during the Performance Period in each case LESS the amount of any Claw-Back.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 121.5pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">(ii)</TD><TD STYLE="text-align: justify">For subsequent years you and the Compensation Committee of the Board (the &ldquo;<B>Committee</B>&rdquo;),
will mutually agree as to the performance targets to earn your annual bonus.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left">(c)</TD><TD STYLE="text-align: justify">You will be provided with an initial grant of options (&ldquo;<B>Initial
Grant</B>&rdquo; to purchase 2,455,000 shares of Common Stock of $0.0001 par value in the Company (&ldquo;<B>Common Stock</B>&rdquo;),
vesting subject to achievement of performance and service conditions as set forth in the option grant attached hereto as <U>Exhibit &ldquo;A&rdquo;</U>.
The grant date of the Initial Grant shall be the third trading day after the announcement of all pending material non-public information
(the &ldquo;MNPI Date&rdquo;). The exercise price of the options shall be equal to the closing price of the Common Stock on the Nasdaq
Stock Market on the MNPI Date. The Exercise Period shall be 10 years commencing on the MNPI Date, the vesting commencement date shall
be the date of this letter and the other terms of the options shall be as set forth in the aforementioned option grant.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 33%"><IMG SRC="ex10-1_002.jpg" ALT="">&nbsp;</TD>
  <TD STYLE="width: 34%">&nbsp;</TD>
  <TD STYLE="width: 33%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Rhoniel A. Daguro</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Page 3</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">March 23, 2023</P>

</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left">(d)</TD><TD STYLE="text-align: justify">The Company wishes and intends to grant you a total award
of 3,570,000 Common Stock but is unable to do so at this time, based on the number of shares available for awards under the Company&rsquo;s
2021 Equity Incentive Plan (the &ldquo;<B>Plan</B>&rdquo;). Accordingly, The Company agrees that as soon as the Company is able to do
so, it will make an additional grant to you of 1,115,000 shares of Common Stock (the &ldquo;<B>Additional Grant</B>&rdquo;), subject
to additional shares becoming available under the Plan and subject to compliance with Company procedures. The Company further agrees
that it will propose a resolution at the next meeting of stockholders in order to approve an increase in the shares of Common Stock allocated
to and available for the grant of awards under the Plan (or the adoption of a new equity plan) sufficient to enable the Additional Grant
to be made. The Exercise Price of the options shall be equal to the closing price of the Common Stock on the Nasdaq Stock Market on the
date of such Additional Grant. The Exercise Period shall be 10 years, the vesting commencement date shall be the date of this letter
and the other terms of the options shall be on substantially the same terms as the Initial Grant. If and to the extent that the Exercise
Price under the Additional Grant is higher than the Exercise Price under the Initial Grant, the following provisions shall apply:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.25in"></TD><TD STYLE="width: 0.25in">(i)</TD><TD STYLE="text-align: justify">The Company shall determine the incremental cost of the Additional Grant by deducting the Exercise Price
of the Initial Grant from the Exercise Price of the Additional Grant and multiplying the difference by 1,115,000 (the &ldquo;<B>Difference</B>&rdquo;).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.25in"></TD><TD STYLE="width: 0.25in">(ii)</TD><TD STYLE="text-align: justify">The Difference determined under sub-paragraph (i) shall be payable to you as a bonus payable upon exercise
of options comprised in the Additional Grant, by way of offset against the Exercise Price of such options to the extent of the total Exercise
Price of the Options being exercised at that time. To the extent that the entire Difference cannot be applied to any particular exercise
pursuant to this Section, the balance shall be carried forward and applied to future exercises of the Additional Grant.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.25in"></TD><TD STYLE="width: 0.25in">(iii)</TD><TD STYLE="text-align: justify">The parties acknowledge that Federal, State and Local income taxes will be payable by you upon the amount
of the Difference at the time it is applied as a bonus hereunder and the Company agrees to be responsible for and to pay such taxes on
your behalf.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.25in"></TD><TD STYLE="width: 0.25in">(iv)</TD><TD STYLE="text-align: justify">However, in lieu of agreeing to pay the bonus pursuant to sub-paragraph (ii) above, the Company may in
its sole discretion elect to grant you an additional 350,000 shares of Common Stock as part of the Additional Grant (for a total of 1,465,000
shares of Common Stock under the Additional Grant), in which case the Company shall have no obligation to pay any bonus or taxes under
sub-sections (ii) and (iii) above.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.25in"></TD><TD STYLE="width: 0.25in">(v)</TD><TD STYLE="text-align: justify">If the Company elects to pay the bonus and taxes under sub-sections (ii) and (iii) above, it shall deliver
to you a statement confirming the amount of the Difference, at the time that it issues the Additional Grant.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.25in"></TD><TD STYLE="width: 0.25in">(vi)</TD><TD STYLE="text-align: justify">If Section 409A of the Code would otherwise apply to any payment or award hereunder, it instead shall
be paid or made at such time as permitted by Section 409A of the Code and the provisions of Section 10.7 of the Executive Retention Agreement
shall apply to this paragraph 5(d).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left">(e)</TD><TD STYLE="text-align: justify">You may be eligible for equity incentive grants and cash
bonus awards, subject to your continued employment and satisfactory job performance, which may be made from time to time, by the Board
or Committee. Terms and conditions of all your equity incentive grants, will be as determined by the Board or Committee and in accordance
with the terms of the Company&rsquo;s equity incentive plan in effect at the time of each such grant.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 33%"><IMG SRC="ex10-1_002.jpg" ALT="">&nbsp;</TD>
  <TD STYLE="width: 34%">&nbsp;</TD>
  <TD STYLE="width: 33%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Rhoniel A. Daguro</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Page 4</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">March 23, 2023</P>

</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left">(f)</TD><TD STYLE="text-align: justify">An Executive Retention Agreement in the form attached hereto
as <U>Exhibit &ldquo;B&rdquo;</U>.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left">(g)</TD><TD STYLE="text-align: justify">All payments made under your employment shall be subject
to deduction of all federal, state, local and other taxes required to be withheld by applicable law.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With respect to additional terms of your employment,
the following will apply:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">1.</TD><TD STYLE="text-align: justify"><B>At Will Employment. </B>Your employment shall start on the signing hereof or such other date as may
be agreed. While we look forward to a long and mutually beneficial relationship, your employment will be &ldquo;at-will&rdquo; and may
be terminated at any time upon written notice and without prior warning. Further, your participation in any stock option or benefit program
are not to be regarded as assuring you of continuing employment for any particular period of time. Any modification or change in your
&ldquo;at-will&rdquo; employment status may only occur by way of a written employment agreement signed by you and authorized by the Board.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">2.</TD><TD STYLE="text-align: justify"><B>Location and Travel.</B> You will work remotely at your home office. As part of your duties you will
be required to travel as necessary to perform your duties and responsibilities, including visiting Group&rsquo;s offices in the locations
where they may exist from time to time and attending Group personnel and team meetings from time to time.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">3.</TD><TD STYLE="text-align: justify"><B>Working Hours</B>. You will be expected to devote your full time and attention to your employment,
to the extent necessary to carry out your duties hereunder. Because of the nature of your position, and as an exempt employee you will
be required to work outside of usual working hours, where the circumstances and business needs require it. You shall not engage or be
involved in any other business activity without the approval of the Board.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">4.</TD><TD STYLE="text-align: justify"><B>Paid Time Off.</B> You will be entitled to Paid Time Off in accordance with the provisions of the Company&rsquo;s
Employee Handbook, which has an unlimited reasonable PTO policy, in addition to all public holidays when the office is closed. Vacation
may be taken upon reasonable prior notice to the Chair of the Board. The Company&rsquo;s Employee Handbook contains further provisions
relating to your entitlement and the taking of Paid Time Off.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">5.</TD><TD STYLE="text-align: justify"><B>Sick &amp; Personal Days.</B> Paid Time Off may be used for sick or personal days. The Company&rsquo;s
Employee Handbook contains further provisions relating to the taking of sick or personal days.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">6.</TD><TD STYLE="text-align: justify"><B>Benefits</B>. You will be eligible to participate in all employee benefit plans established by the
Company for its employees from time to time. The Company currently offers the benefits that are detailed in the Employee Handbook.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">7.</TD><TD STYLE="text-align: justify"><B>Expense Reimbursement.</B> In accordance with Company policies from time to time, we will reimburse
you for all reasonable and proper travel and business expenses incurred by you in the performance of your duties.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">8.</TD><TD STYLE="text-align: justify"><B>Confidentiality and Assignment of Inventions</B>. As an employee and executive of the Company, you
will have access to certain confidential information of the Company and you may, during the course of your employment, develop certain
information or inventions that will be the property of the Company. To protect the interests of the Company, you will need to sign the
Company's standard &quot;Employee Invention Assignment and Confidentiality Agreement&quot; in the form attached hereto as <U>Exhibit &ldquo;C&rdquo;</U>
as a condition of your employment.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 33%"><IMG SRC="ex10-1_002.jpg" ALT="">&nbsp;</TD>
  <TD STYLE="width: 34%">&nbsp;</TD>
  <TD STYLE="width: 33%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Rhoniel A. Daguro</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Page 5</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">March 23, 2023</P>

</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">9.</TD><TD STYLE="text-align: justify"><B>Covenant Not to Compete. </B>During the term of this Agreement and, with respect to paragraphs 9(b)
and (c) only, for the period of six (6) months after the termination of your employment by any member of the Group for any reason whatsoever,
you shall not directly or indirectly:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">be employed, or engaged as an independent contractor, consultant, or in any position where your responsibilities
would require you to directly or indirectly support/work on services and/or products that are in competition with the Group&rsquo;s businesses
as they exist during your employment -- the Group&rsquo;s businesses currently consist of its biometric identity verification products
and services;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><I>&nbsp;</I></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">whether as an employee, independent contractor, consultant, advisor, or principal, enter into any agreement
which is for the provision of services in competition with any of the Group&rsquo;s businesses, as they exist during your employment or
on the date of your separation from the Company, with any entity, which is or was a customer of the Group (or was in negotiation to become
a customer of the Group), as of or at any time within six (6) months prior to your separation date, nor cause any such customer to enter
into any such agreement for competitive services with any third party.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">whether on your own behalf or on behalf of any other person or entity (i) directly or indirectly solicit
any employee of the Group to discontinue such employment relationship with the Group; or (ii) employ or seek to employ any person who
is or was employed by the Group as of or at any time within six (6) months prior to your separation date.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">You acknowledge that the restrictions
set forth in this paragraph are reasonable and necessary for the protection of the Group&rsquo;s legitimate interests, in particular having
regard to the sensitive position which you will hold and the high level of confidential and proprietary information regarding the Group&rsquo;s
business operations, systems and customers to which you will have access, during the performance of your duties hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Please note that this paragraph contains
provisions which may be covered by the Illinois Freedom to Work Act and you are advised to consult with an attorney before signing this
Agreement. You have 14 days from the date of delivery of the first draft of this Offer Letter to review this paragraph in particular.
Such period shall not be restarted by any amendments to this Letter and you may accept and sign this Letter at any time after we mutually
agree it is in final form acceptable to both parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">10.</TD><TD STYLE="text-align: justify"><B>Pre-existing obligations. </B>You hereby warrant and represent that you are not subject to any restrictive
covenant, or other agreement, which would prevent you from accepting this offer or from performing your obligations hereunder. To the
extent that you are subject to confidentiality obligations to a former employer or any third party, you acknowledge and agree that it
is your responsibility to ensure that you comply with such obligations. You acknowledge that the Company is relying upon your warranty,
representation and acknowledgement in this paragraph in making this offer to you. In the event of any claim against you or the Group by
any third party arising out of a knowing breach of this paragraph, you agree to indemnify and hold the Group (and its directors, officers
and employees) harmless from and against all costs, claims and damages arising from such third party&rsquo;s claim.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 33%"><IMG SRC="ex10-1_002.jpg" ALT="">&nbsp;</TD>
  <TD STYLE="width: 34%">&nbsp;</TD>
  <TD STYLE="width: 33%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Rhoniel A. Daguro</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Page 6</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">March 23, 2023</P>

</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">11.</TD><TD STYLE="text-align: justify"><B>Governing Law &amp; Jurisdiction.</B> This offer and your employment shall be governed by and construed
in accordance with the laws of the State of Illinois. You and the Company agree to submit to the exclusive personal jurisdiction of the
federal and state courts located in Illinois, in connection with any dispute or proceedings arising out of or relating to this offer and
your employment, and each of us hereby submits to the exclusive jurisdiction of such courts. To the extent of a conflict between this
Section 11 and provisions of your Executive Retention Agreement, your Executive Retention Agreement shall prevail.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">12.</TD><TD STYLE="text-align: justify"><B>Amendment. </B>No amendment or waiver of any of the provisions hereof shall be effective, unless in
writing and signed by each party.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27.35pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">13.</TD><TD STYLE="text-align: justify"><B>Other Documents.</B> Your employment is subject to the Employment Handbook and terms and conditions
(including benefits) applicable generally to employees of the Group, from time to time in force, which are subject to change, amendment,
or deletion in the Company&rsquo;s sole discretion. As a condition of your employment you will also be required to enter into certain
standard undertakings and consents regarding security, confidentiality and use of the Group&rsquo;s facilities and property. As part of
our objective of continuous improvement and in order to comply with certain customer and audit requirements, you will also be required
to undergo training at least annually on various matters including data security. In accordance with our standard policy this employment
offer is subject to our receiving satisfactory references and civil and criminal background checks, and by signing this letter you hereby
consent to our undertaking such reference and background checks.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">14.</TD><TD STYLE="text-align: justify"><B>Authorization to Work.</B> Please note that because of employer regulations adopted in the Immigration
Reform and Control Act of 1986, within three (3) business days of starting your new position you will need to present documentation demonstrating
that you have authorization to work in the United States.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">15.</TD><TD STYLE="text-align: justify"><B>Severability. </B>If any provision of this letter or the application thereof is held invalid by a court,
arbitrator or government agency of competent jurisdiction, you agree that such a determination of invalidity shall not affect other provisions
or applications of the letter which can be given effect without the invalid provisions and thus shall remain in full force and effect
or application.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the terms and the conditions
of this letter are acceptable to you, please sign, date and return an original of this letter to us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 33%"><IMG SRC="ex10-1_002.jpg" ALT="">&nbsp;</TD>
  <TD STYLE="width: 34%">&nbsp;</TD>
  <TD STYLE="width: 33%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Rhoniel A. Daguro</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Page 7</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">March 23, 2023</P>

</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We look forward to a long
and mutually beneficial relationship.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Sincerely,</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 40%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 20%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 4%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 36%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-size: 10pt; font-variant: small-caps">authID Inc.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify"><FONT STYLE="font-size: 10pt">/s/ Thomas L. Thimot</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Thomas L. Thimot, CEO</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">AGREED &amp; ACCEPTED:</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify"><FONT STYLE="font-size: 10pt">/s/ RHONIEL A. DAGURO</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RHONIEL A. DAGURO</FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:&nbsp;&nbsp;<U>March 23, 2023</U></FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>authID INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NON-STATUTORY STOCK OPTION AGREEMENT</B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-variant: small-caps">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps"><B>This
Non-Statutory Stock Option Agreement </B></FONT>(&quot;<B>Agreement</B>&quot;) is made and entered into as of the date set forth below,
by and between authID Inc., a Delaware corporation (the &quot;<B>Company</B>&quot;), and the following director, employee or consultant
of the Company (&quot;<B>Optionee</B>&quot;):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In consideration of the covenants
herein set forth, the parties hereto agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">1.</TD><TD STYLE="text-align: justify"><U>Option Information.</U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 8%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="width: 24%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date of Option:</FONT></TD>
    <TD STYLE="width: 68%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Optionee:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rhoniel A. Daguro</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of Shares:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><U>2,455,000</U></I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise Price:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><U>[NTD &ndash; TBD on 3<SUP>rd</SUP> day after announcement of pending MNPI]</U></I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expiration Date:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><U>[NTD - 10 years]</U></I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vesting:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with Section 5.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">2.</TD><TD STYLE="text-align: justify"><U>Acknowledgements.</U></TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                                                                                                </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)
Optionee is an Employee of the Company or one of its subsidiaries and has entered into an Executive Retention Agreement with the Company
dated as of March 23, 2023 (&ldquo;<B>Optionee&rsquo;s Executive Retention Agreement</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>The Board of Directors (the &quot;<B>Board</B>&quot; which term shall include an authorized committee of the Board of Directors)
and shareholders of the Company have heretofore adopted a 2021 Equity Incentive Plan (the &quot;<B>Plan</B>&quot;), pursuant to which
this Option is being granted and which Plan is registered under the Securities Act of 1933, as amended (the &quot;<B>Securities Act</B>&quot;);
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>The Board has authorized the granting to Optionee of a non-statutory stock option (&quot;<B>Option</B>&quot;) to purchase shares
of common stock of the Company (&quot;<B>Stock</B>&quot;) upon the terms and conditions hereinafter stated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Shares; Price.</U> Company hereby grants to Optionee the right to purchase, upon and subject to the terms and conditions herein
stated, the number of shares of Stock set forth in Section 1(c) above (the &quot;<B>Shares</B>&quot;) for cash, pursuant to a Cashless
Exercise as set forth in Section 6(b), or for other consideration as is authorized under the Plan and acceptable to the Board, in its
sole and absolute discretion) at the price per Share set forth in Section 1(d) above (the &quot;<B>Exercise Price</B>&quot;), such price
being not less than the fair market value per share of the Shares covered by this Option as of the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Term of Option; Continuation of Service.</U> This Option shall expire, and all rights hereunder to purchase the Shares shall
terminate, ten (10) years from the date hereof, as set forth in Section 1(e) above (&ldquo;<B>Expiration Date</B>&rdquo;). This Option
shall earlier terminate subject to Sections 7 and 8 hereof upon and as of the date of, the termination of Optionee's office or employment
if such termination occurs prior to the Expiration Date. Nothing contained herein shall confer upon Optionee the right to the continuation
of his or her office or employment with the Company or to interfere with the right of the Company to terminate such office or employment
or to increase or decrease the compensation of Optionee from the rate in existence at the date hereof. In the event of a conflict between
this Section 4 and provisions of Optionee&rsquo;s Executive Retention Agreement, Optionee&rsquo;s Executive Retention Agreement shall
prevail.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 8; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Vesting of Option.</U> Subject to the provisions of Sections 7 and 8 hereof, this Option shall become exercisable and the Shares
shall vest during the term of Optionee's office or employment as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD STYLE="text-align: justify">420,000 of the Shares shall vest and become exercisable upon the date of grant:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(b)</TD><TD STYLE="text-align: justify">2,035,000 of the Shares shall vest and become exercisable as to 56,528 of the Shares covered by this Option
at the end of each month commencing with the month following the date of this Option, over a period of thirty-six (36) months, subject
to Optionee&rsquo;s continued service to the Company, subject to earlier vesting pursuant to the remaining sub-sections of this Section
5.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(c)</TD><TD STYLE="text-align: justify">To the extent not already vested pursuant to Section 5(b) above, 508,750 of the Shares shall also vest
and become exercisable upon each satisfaction of each of the following metrics having the following conditions:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">(i)</TD><TD STYLE="text-align: justify">The Company&rsquo;s Shares achieving a price on the principal market or exchange on which such shares
are traded, which gives rise to a Market Capitalization (as defined below) of the Company of not less than $50,000,000 for a period of
not less than thirty (30) consecutive Trading Days (as defined below);</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                                                </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">(ii)</TD><TD STYLE="text-align: justify">The Company&rsquo;s Shares achieving a price on the principal market or exchange on which such shares
are traded, which gives rise to a Market Capitalization (as defined below) of the Company of not less than $100,000,000 for a period of
not less than thirty (30) consecutive Trading Days (as defined below);</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                                                </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">(iii)</TD><TD STYLE="text-align: justify">The Company&rsquo;s Shares achieving a price on the principal market or exchange on which such shares
are traded, which gives rise to a Market Capitalization (as defined below) of the Company of not less than $150,000,000 for a period of
not less than thirty (30) consecutive Trading Days (as defined below);</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
                                                                                </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">(iv)</TD><TD STYLE="text-align: justify">The Company&rsquo;s Shares achieving a price on the principal market or exchange on which such shares
are traded, which gives rise to a Market Capitalization (as defined below) of the Company of not less than $200,000,000 for a period of
not less than thirty (30) consecutive Trading Days (as defined below);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(d)</TD><TD STYLE="text-align: justify">Upon the occurrence of a Termination upon Change of Control (as defined in Optionee&rsquo;s Executive
Retention Agreement), prior to the occurrence of any of the other vesting conditions, 100% of the Shares subject to this Option shall
vest to the extent not previously vested.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(e)</TD><TD STYLE="text-align: justify">&ldquo;<B>Change of Control</B>&rdquo; shall have the meaning set forth in Optionee&rsquo;s Executive
Retention Agreement, except if any of the events set forth in such Agreement occurs in circumstances of the liquidation of the Company
pursuant to a bankruptcy, or other insolvency proceeding.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(f)</TD><TD STYLE="text-align: justify">&ldquo;<B>Market Capitalization</B>&rdquo; shall mean the amount which results from the following calculations
or determinations:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">(i)</TD><TD STYLE="text-align: justify">the VWAP of the Shares during the 30 Trading Days immediately prior to each date on which the Market Capitalization
is to be determined multiplied by the aggregate of the number of issued and outstanding Shares of common stock on the relevant date;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(f)</TD><TD STYLE="text-align: justify">&ldquo;<B>Trading Day</B>&rdquo; means a day on which the principal trading market for the Shares is open
for trading.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(g)</TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">&ldquo;<B>VWAP</B>&rdquo; shall mean, for Shares as of any date,
the dollar volume-weighted average price for such security on the principal market or exchange on which the Shares are traded during each
Trading Day as reported by Nasdaq or such other principal market or exchange.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The installments shall be cumulative (i.e., this
option may be exercised, as to any or all Shares covered by an installment, at any time or times after an installment becomes exercisable
and until expiration or termination of this Option). If any Share vesting has not occurred before the earlier of the expiration or termination
date of this Option, or termination of the Optionee&rsquo;s service to the Company, the Option shall lapse as to the unvested Shares.
In the event of a conflict between this Section 5 and provisions of Optionee&rsquo;s Executive Retention Agreement, Optionee&rsquo;s Executive
Retention Agreement shall prevail.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">6.</TD><TD STYLE="text-align: justify"><U>Exercise.</U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Standard Exercise.</U> This Option shall be exercised by delivery to the Company of (i) written notice of exercise stating the
number of Shares being purchased (in whole shares only) and such other information set forth on the form of Notice of Exercise attached
hereto as <U>Appendix A</U>; and (ii) a check or wire transfer in the amount of the Exercise Price of the Shares covered by the notice
(or such other consideration as has been approved by the Board consistent with the Plan) and any taxes (including withholding taxes) payable
by the Optionee upon exercise. This Option shall not be assignable or transferable, except by will or by the laws of descent and distribution,
and shall be exercisable only by Optionee during his or her lifetime, except as provided in Section 8 hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Cashless Exercise.</U> Notwithstanding anything to the contrary contained in this Option, this Option may be exercised by presentation
and surrender of this Option to the Company at its principal executive offices with (i) a written notice of the holder&rsquo;s intention
to effect a cashless exercise, and such other information set forth on the form of Notice of Exercise attached hereto as <U>Appendix A,</U>
(a &ldquo;<B>Cashless Exercise</B>&rdquo;); and (ii) a check or wire transfer in the amount of any taxes (including withholding taxes)
payable by the Optionee upon exercise. In the event of a Cashless Exercise, in lieu of paying the Exercise Price in cash, the holder shall
surrender this Option for that number of shares of Common Stock determined by multiplying the number of Shares to which it would otherwise
be entitled by a fraction, the numerator of which shall be the difference between the then current Market Price per share of the Common
Stock and the Exercise Price, and the denominator of which shall be the then current Market Price per share of Common Stock. Market Price
is defined as the average of the last reported sale prices on the principal trading market for the Common Stock during the five (5) trading
days immediately preceding such exercise date. Market Price and the number of Shares issuable on a Cashless Exercise shall be as calculated
by the Company, whose determination thereof shall be final save in the case of mathematical or other manifest error.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Further, if implemented by the Company,
all or part of the Exercise Price and any taxes (including withholding taxes) may be paid by the delivery (on a form prescribed by the
Company) of an irrevocable direction to a securities broker approved by the Company to sell Shares and to deliver all or part of the sales
proceeds to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Termination of Employment.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>If Optionee ceases to be a director, employee or contractor (i.e., Optionee ceases all such positions held) of the Company for
any reason, whether voluntarily or involuntarily, other than by his or her death, Optionee (or if the Optionee shall die after such termination,
but prior to such exercise date, Optionee's personal representative or the person entitled to succeed to the Option) shall have the right
at any time within three (3) months following such termination of office or the remaining term of this Option, whichever is the lesser,
to exercise in whole or in part this Option to the extent, but only to the extent, that this Option was exercisable as of the date of
termination of office and had not previously been exercised; provided, however: (i) if Optionee is permanently disabled (within the meaning
of Section 22(e)(3) of the Code) at the time of termination, the foregoing three (3) month period shall be extended to one (1) year; or
(ii) if Optionee is terminated &quot;<I>for cause</I>&quot; (as defined below) this Option shall automatically terminate as to all Shares
covered by this Option not exercised prior to termination. Unless earlier terminated, all rights under this Option shall terminate in
any event on the Expiration Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>If the term &quot;<I>for cause</I>&quot; is defined in any employment agreement (including any Executive Retention Agreement) between
the Optionee and the Company, then such definition shall be used. <FONT STYLE="background-color: white">&ldquo;<I>For Cause</I>&rdquo;
in this Agreement means commission by Optionee against the Company of (i) an intentional act of fraud, embezzlement, theft or any other
material violation of law that occurs during and in the course of Optionee&rsquo;s employment or office with Company; (ii) intentional
damage to the Company&rsquo;s assets; (iii) intentional disclosure of Company&rsquo;s confidential information contrary to the Company&rsquo;s
policies; (iv) a material breach of Optionee&rsquo;s obligations to the Company; (v) intentional engagement in any competitive activity
which would constitute a material breach of Optionee&rsquo;s duty of loyalty or of Optionee&rsquo;s obligations to the Company; (vi) a
knowing and intentional breach of any material provisions of Company&rsquo;s written policies communicated to Optionee; (vii) the willful
and continued failure following written notice to substantially perform Optionee&rsquo;s duties for Company (other than as a result of
incapacity due to physical or mental illness); or (viii) willful conduct by Optionee that is demonstrably and materially injurious to
the Company, monetarily or otherwise. A &ldquo;<I>For Cause</I>&rdquo; determination shall be made only upon the unanimous vote of the
Company&rsquo;s Board (excluding Optionee, should he or she be a Board member).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>In the event of a conflict between this Section 7 and provisions of Optionee&rsquo;s Executive Retention Agreement, Optionee&rsquo;s
Executive Retention Agreement shall prevail.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Death of Optionee.</U> If the Optionee shall die while holding office of the Company, Optionee's personal representative or
the person entitled to Optionee's rights hereunder may at any time within one (1) year after the date of Optionee's death, or during the
remaining term of this Option, whichever is the lesser, exercise this Option and purchase Shares to the extent, but only to the extent,
that Optionee could have exercised this Option as of the date of Optionee's death; provided, in any case, that this Option may be so exercised
only to the extent that this Option has not previously been exercised by Optionee. In the event of a conflict between this Section 8 and
provisions of Optionee&rsquo;s Executive Retention Agreement, Optionee&rsquo;s Executive Retention Agreement shall prevail.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>No Rights as Shareholder.</U> Optionee shall have no rights as a shareholder with respect to the Shares covered by any installment
of this Option until the effective date of issuance of the Shares following exercise of this Option, and no adjustment will be made for
dividends or other rights for which the record date is prior to the date such Shares are issued except as provided in Section 10 hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">10.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Recapitalization.</U> Subject to any required action by the shareholders of the Company, the number of Shares covered by this
Option, and the Exercise Price thereof, shall be proportionately adjusted for any increase or decrease in the number of issued shares
resulting from a subdivision or consolidation of shares or the payment of a stock dividend, or any other increase or decrease in the number
of such shares effected without receipt of consideration by the Company; provided however that the conversion of any convertible securities
of the Company shall not be deemed having been &quot;effected without receipt of consideration by the Company&quot;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">11.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Reorganization.</U> The grant of this Option shall not affect in any way the right or power of the Company to make adjustments,
reclassifications, reorganizations or changes in its capital or business structure or to merge, consolidate, dissolve or liquidate or
to sell or transfer all or any part of its business or assets. The provisions of the Plan shall govern the rights of the Optionee in the
event of a Reorganization as defined in the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">12.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Taxation upon Exercise of Option.</U> Optionee understands that, upon exercise of this Option, Optionee will recognize income,
for Federal and state income tax purposes, in an amount equal to the amount by which the fair market value of the Shares, determined as
of the date of exercise, exceeds the Exercise Price. The acceptance of the Shares by Optionee shall constitute an agreement by Optionee
to report such income in accordance with then applicable law and to cooperate with Company in establishing the amount of such income and
corresponding deduction to the Company for its income tax purposes. Withholding for federal or state income and employment tax purposes
will be made, if and as required by law, from Optionee's then current compensation, or, if such current compensation is insufficient to
satisfy withholding tax liability, the Company may require Optionee to make a cash payment to cover such liability as a condition of the
exercise of this Option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">13.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Modification, Extension and Renewal of Options.</U> The Board or Committee, as described in the Plan, may modify, extend or
renew this Option or accept the surrender thereof (to the extent not theretofore exercised) and authorize the granting of a new option
in substitution therefore (to the extent not theretofore exercised), subject at all times to the Plan, the Code and all relevant securities
statutes and rules. Notwithstanding the foregoing provisions of this Section 13, no modification shall, without the consent of the Optionee,
alter to the Optionee's detriment or impair any rights of Optionee hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">14.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Stand-off Agreement.</U> Optionee agrees that, in connection with any registration of the Company's securities under the Securities
Act, and upon the request of the Company or any underwriter managing an underwritten offering of the Company's securities, Optionee shall
not sell, short any sale of, loan, grant an option for, or otherwise dispose of any of the Shares (other than Shares included in the offering)
without the prior written consent of the Company or such managing underwriter, as applicable, for a period of at least six months following
the effective date of registration of such offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">15.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Notices.</U> Any notice required to be given pursuant to this Option or the Plan shall be in writing and delivered to the Company
Attn: General Counsel and shall be deemed to be delivered upon receipt, or by e-mail to legal@authid.ai, or in the case of notices by
the Company, five (5) days after deposit in the U.S. mail, postage prepaid, or by e-mail addressed to Optionee at the address last provided
by Optionee for his or her employee/officer records.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">16.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Agreement Subject to Plan; Applicable Law.</U> This Option is made pursuant to the Plan and shall be interpreted to comply therewith.
A copy of such Plan is available to Optionee, at no charge, at the principal office of the Company. Any provision of this Option inconsistent
with the Plan shall be considered void and replaced with the applicable provision of the Plan, except to the extent expressly approved
by the Board. This Option has been granted, executed and delivered in the State of Delaware, and the interpretation and enforcement shall
be governed by the laws thereof and subject to the exclusive jurisdiction of the courts therein, except as otherwise provided in Optionee&rsquo;s
Executive Retention Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">17.<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Data Privacy Consent</U>. In order to administer the Plan and this Agreement and to implement or structure future equity grants,
the Company, its subsidiaries and affiliates and certain agents thereof (together, the &ldquo;<B>Relevant Companies</B>&rdquo;) may process
any and all personal or professional data, including but not limited to Social Security or other identification number, home address and
telephone number, date of birth and other information that is necessary or desirable for the administration of the Plan or this Agreement
(the &ldquo;<B>Relevant Information</B>&rdquo;). By entering into this Agreement, the Optionee (i) authorizes the Company to collect,
process, register and transfer to the Relevant Companies all Relevant Information; (ii) authorizes the Relevant Companies to store and
transmit such information in electronic form; and (iii) authorizes the transfer of the Relevant Information to any jurisdiction which
the Relevant Companies consider appropriate. The Optionee shall have access to, and the right to change, the Relevant Information. Relevant
Information will only be processed and used in accordance with applicable law and in accordance with the Company&rsquo;s privacy policy
from time to time in force.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Signature page follows]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I></I></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps"><B>In
Witness Whereof</B></FONT>, the parties hereto have executed this Option Agreement as of the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><B>COMPANY:</B></TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-variant: small-caps">authID Inc.,</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">a Delaware corporation</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 5%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 35%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">Name:&nbsp;</TD>
    <TD STYLE="text-align: justify">Hang Thi Bich Pham</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>Chief Financial Officer</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><B><I>OPTIONEE:</I></B></TD>
    <TD STYLE="text-align: justify"></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">(<I>signature</I>)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD>Rhoniel A. Daguro</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Appendix A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">authID Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Re: Non-statutory Stock
Option</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notice is hereby given pursuant
to Section 6 of my Non-statutory Stock Option Agreement that I elect to purchase the number of shares set forth below at the exercise
price set forth in my option agreement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Non-statutory Stock Option
Agreement dated: ____________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Number of shares being purchased:
____________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Exercise Price: $____________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>EITHER</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1)<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT>A check in the amount of the aggregate price of the shares being purchased is attached/wire transfer for such amount is being sent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">OR</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2)  I
elect a cashless exercise pursuant to Section 6 of my Stock Option Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company shall determine the Market Price*
as of the date of this Exercise Notice and the resulting number of shares of common stock to be issued on a cashless exercise basis and
promptly notify the Option holder thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left">*</TD><TD STYLE="text-align: justify">Market Price is defined as the average of the last reported
sale prices on the principal trading market for the Common Stock during the five (5) trading days immediately preceding such exercise
date.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Further, I understand that
the exercise of the Options will give rise to taxable income at the time of exercise, and that taxes will be payable in addition to the
Exercise Price under the Option, whether by deduction from my compensation, or by my additional payment to the Company.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">I agree to provide to the
Company such additional documents or information as may be required pursuant to the Company's 2021 Equity Incentive Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 7%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 33%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">EXECUTIVE RETENTION AGREEMENT</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Executive Retention Agreement
(the &ldquo;<B><I>Agreement</I></B>&rdquo;) is made and entered into as of March 23 2023 by and between AUTHID INC., a Delaware corporation
(the &ldquo;<B><I>Company</I></B>&rdquo;), and RHONIAL A. DAGURO (the &ldquo;<B><I>Executive</I></B>&rdquo;).</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0">Recitals:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Executive is
a key employee of the Company who possesses valuable proprietary knowledge of the Company, its business and operations and the markets
in which the Company competes; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Company and the
Executive desire to enter into this Agreement to encourage the Executive to continue to devote the Executive&rsquo;s full attention and
dedication to the success of the Company, and to provide specified compensation and benefits to the Executive in the event of a Termination
Upon Change of Control or certain other terminations pursuant to the terms of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">NOW, THEREFORE, THE PARTIES HEREBY AGREE AS FOLLOWS:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-transform: uppercase">1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></FONT><FONT STYLE="font-size: 10pt"><U>PURPOSE AND TERM</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The purpose of this Agreement
is to provide specified compensation and benefits to the Executive in the event of (i) a Termination Upon Change of Control or (ii) an
Involuntary Termination. Subject to the terms of any applicable written employment agreement between Company and the Executive (as to
which Executive acknowledges no other such agreement exists as of the date hereof beyond the Employment Offer letter dated March 23, 2023),
either the Executive or Company may terminate the Executive&rsquo;s employment at any time for any reason, with or without notice. The
term of this Agreement shall be the period from the date set forth above until Executive&rsquo;s employment is terminated for any reason
or this Agreement is terminated by mutual agreement of the parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-transform: uppercase">2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></FONT><FONT STYLE="font-size: 10pt"><U>TERMINATION GENERALLY</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">2.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Termination of Employment Generally</U>. In the event the Executive&rsquo;s employment with the
Company terminates, for any reason whatsoever including death or disability the Executive shall be entitled to the benefits described
in this Section 2.1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.1.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Accrued Salary and Vacation</U>. All salary and accrued vacation earned through the Termination
Date shall be paid to Executive on such Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.1.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Accrued Bonus Payment</U>. The Executive shall receive a lump sum payment of any actual bonus
amount to the extent that all the conditions for payment of such bonus have been satisfied and any such bonus was earned and is unpaid
on the Termination Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.1.3<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Expense Reimbursement</U>. Within ten (10) days following submission to the Company of proper
expense reports by the Executive, the Company shall reimburse the Executive for all expenses incurred by the Executive, consistent with
the Company&rsquo;s expense reimbursement policy in effect prior to the incurring of each such expense, in connection with the business
of the Company prior to the Termination Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="text-transform: uppercase">3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></FONT><FONT STYLE="font-size: 10pt"><U>TERMINATION UPON CHANGE OF CONTROL</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">3.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Severance Payment</U>. In the event of the Executive&rsquo;s Termination Upon Change of Control,
the Executive shall be entitled to receive an amount equal to twelve (12) months of the Executive&rsquo;s Base Salary and 100% of Executive&rsquo;s
target annual bonus for the year in which the Termination Date occurs (or, if greater, the target annual bonus in effect immediately prior
to the Change of Control) which shall be paid in a lump sum payment within ten (10) days following the Termination Date; provided, however,
that if Section 409A of the Code would otherwise apply to such cash severance payment, it instead shall be paid at such time as permitted
by Section 409A of the Code. The severance payment payable hereunder shall be reduced to the extent of the amount of any bonus payable
to Executive upon a Change of Control. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">3.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-size: 10pt"><U>COBRA</U>. The Company will reimburse Executive for the cost of continuation of health coverage
for Executive and Executive&rsquo;s eligible dependents pursuant to the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended
(&ldquo;<B><I>COBRA</I></B>&rdquo;) until the earlier of (i) 12 months following the Termination Date, (ii) the date Executive is eligible
for health coverage for Executive and Executive&rsquo;s eligible dependents from a new employer or (iii) the date Executive and Executive&rsquo;s
eligible dependents are no longer eligible for COBRA; provided, however, if, at the time of the Termination Date, the Company determines
that providing the COBRA reimbursement in this paragraph would result in a violation of law or an excise tax to the Company, then the
Company instead will pay a lump sum payment equal to 150% of 12 months of Executive&rsquo;s estimated COBRA premiums, less applicable
withholdings, within 10 days following the Termination Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">3.3<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Equity Compensation Acceleration</U>. Upon the Executive&rsquo;s Termination Upon Change of Control,
the vesting and exercisability of all then outstanding stock options and shares of restricted stock (or any other equity award, including,
without limitation, stock appreciation rights and restricted stock units) granted to the Executive under any Company Plans shall be accelerated
as to 100% of the shares subject to any such equity awards granted to the Executive. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">3.4<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Equity Compensation Exercise</U>. Upon the Executive&rsquo;s Termination Upon Change of Control,
the Exercise Period with respect to vested Shares, under the Company Plans for the purposes of the Executive&rsquo;s stock options granted
under the Company Plans shall be extended so as to expire one (1) year from the date of Involuntary Termination or the remaining term
of the relevant equity award, whichever is the lesser. All other unvested Shares under any such grants or other equity awards not subject
to acceleration under Section 3.3 shall lapse and no longer be exercisable as of the date of Involuntary Termination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">3.5<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Indemnification</U>. In the event of the Executive&rsquo;s Termination Upon Change of Control,
(a) the Company shall continue to indemnify the Executive against all claims related to actions arising prior to the termination of the
Executive&rsquo;s employment to the fullest extent permitted by law, and (b) if the Executive was covered by the Company&rsquo;s directors&rsquo;
and officers&rsquo; insurance policy, or an equivalent thereto, (the &ldquo;<B><I>D&amp;O Insurance Policy</I></B>&rdquo;) immediately
prior to the Change of Control, the Company or its Successor shall continue to provide coverage under a D&amp;O Insurance Policy for not
less than twenty-four (24) months following the Executive&rsquo;s Termination Upon Change of Control on substantially the same terms of
the D&amp;O Insurance Policy in effect immediately prior to the Change of Control. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="text-transform: uppercase">4.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></FONT><FONT STYLE="font-size: 10pt"><U>INVOLUNTARY TERMINATION</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">4.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Severance Payment</U>. In the event of the Executive&rsquo;s Involuntary Termination, the Executive
shall be entitled to receive an amount equal to twelve (12) months of the Executive&rsquo;s Base Salary, which shall be paid according
to the following schedule: (i) a lump sum payment equal to one-fourth of such amount shall be payable within ten (10) days following the
Termination Date, and (ii) one-fourth of such amount shall be payable within ten (10) days of each of the three-month, six-month and nine-month
anniversaries of the Termination Date (and in each case no interest shall accrue on such amount); provided, however, that if Section 409A
of the Code would otherwise apply to such cash severance payment, it instead shall be paid at such time as permitted by Section 409A of
the Code. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">4.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-size: 10pt">Bonus Payment. In addition to the foregoing severance payment, in the event of the Executive&rsquo;s
Involuntary Termination, the Executive shall be entitled to receive, within ten (10) days following the Executive&rsquo;s Involuntary
Termination, a lump sum payment equal to one hundred percent (100%) of any actual bonus amount earned with respect to a previous year
to the extent that all the conditions for payment of such bonus have been satisfied (excluding any requirement to be in employment with
the Company as of a given date which is after the Termination Date) and any such bonus was earned but is unpaid on the Termination Date.
</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">4.3<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-size: 10pt"><U>COBRA</U>. The Company will reimburse Executive for the cost of continuation of health coverage
for Executive and Executive&rsquo;s eligible dependents pursuant to COBRA until the earlier of (i)&nbsp;12 months following the Termination
Date, (ii) the date Executive is eligible for health coverage for Executive and Executive&rsquo;s eligible dependents from a new employer
or (iii) the date Executive and Executive&rsquo;s eligible dependents are no longer eligible for COBRA; provided, however, if, at the
time of the Termination Date, the Company determines that providing the COBRA reimbursement in this paragraph would result in a violation
of law or an excise tax to the Company, then the Company instead will pay a lump sum payment equal to 150% of 12 months of Executive&rsquo;s
estimated COBRA premiums, less applicable withholdings, within 10 days following the Termination Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">4.4<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Equity Compensation Exercise</U>. Upon the Executive&rsquo;s Involuntary Termination, the Exercise
Period with respect to vested Shares, under the Company Plans for the purposes of the Executive&rsquo;s stock options granted under the
Company Plans shall be extended so as to expire one (1) year from the date of Involuntary Termination or the remaining term of the relevant
equity award, whichever is the lesser. All other unvested Shares under any such grants or other equity awards shall lapse and no longer
be exercisable as of the date of Involuntary Termination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">4.5<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Indemnification</U>. In the event of the Executive&rsquo;s Involuntary Termination, (a) the Company
shall continue to indemnify the Executive against all claims related to actions arising prior to the Termination Date to the fullest extent
permitted by law, and (b) if the Executive was covered by the D&amp;O Insurance Policy immediately prior to the Termination Date, the
Company shall continue to provide coverage under a D&amp;O Insurance Policy for not less than twenty-four (24) months following the Executive&rsquo;s
Involuntary Termination on substantially the same terms of the D&amp;O Insurance Policy in effect immediately prior to the Termination
Date. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-transform: uppercase">5.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></FONT><FONT STYLE="font-size: 10pt"><U>FEDERAL EXCISE TAX UNDER SECTION 280G</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">5.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Excise Tax</U>. If (a) any amounts payable to the Executive under this Agreement or otherwise
are characterized as excess parachute payments pursuant to Section 4999 of the Internal Revenue Code of 1986, as amended (the &ldquo;<B><I>Code</I></B>&rdquo;),
and (b) the Executive thereby would be subject to any United States federal excise tax due to that characterization, then such amounts
will either be (i)&nbsp;delivered in full, or (ii) delivered to such lesser extent which would result in no portion of such amounts being
subject to excise tax pursuant to Section 4999 of the Code, whichever of the foregoing amounts, taking into account the applicable federal,
state and local income taxes and the excise tax imposed by Code Section 4999, results in Executive&rsquo;s receipt on an after-tax basis,
of the greatest amounts, notwithstanding that all or some portion of such amounts may be taxable under Code Section 4999. If a reduction
in the amounts constituting &ldquo;parachute payments&rdquo; is necessary so that no portion of such amounts are subject to the excise
tax under Code Section 4999, the reduction will occur in the following order: (i)&nbsp;reduction of the cash severance payments, which
will occur in reverse chronological order such that the cash payment owed on the latest date following the occurrence of the event triggering
such excise tax will be the first cash payment to be reduce; (ii) cancellation of accelerated vesting of equity awards which will occur
in the reverse order of the date of grant for such stock awards (i.e., the vesting of the most recently granted stock awards will be reduced
first); and (iii) reduction of continued employee benefits, which will occur in reverse chronological order such that the benefit owed
on the latest date following the occurrence of the event triggering such excise tax will be the first benefit to be reduced. If two or
more equity awards are granted on the same date, each award will be reduced on a pro-rata basis. Notwithstanding the foregoing, no such
reduction or elimination shall apply to any non-qualified deferred compensation amounts (within the meaning of Section 409A of the Code)
to the extent such reduction or elimination would accelerate or defer the timing of such payment in a manner that does not comply with
Section 409A of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">5.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Calculation by Independent Public Accountants</U>. Unless the Company and the Executive otherwise
agree in writing, any calculation of the amount of any excess parachute payments payable by the Executive shall be made in writing by
the Company&rsquo;s independent public accountants (the &ldquo;<B><I>Accountants</I></B>&rdquo;) whose conclusion shall be final and binding
on the parties. For purposes of making such calculations, the Accountants may rely on reasonable, good faith interpretations concerning
the application of Sections 280G and 4999 of the Code. The Company and the Executive shall furnish to the Accountants such information
and documents as the Accountants may reasonably request in order to make the required calculations. The Company shall bear all fees and
expenses the Accountants may charge in connection with these services, but the engagement of the Accountants for this purpose shall be
pursuant to an agreement between the Executive and the Accountants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-transform: uppercase">6.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></FONT><FONT STYLE="font-size: 10pt"><U>DEFINITIONS</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">6.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Capitalized Terms Defined</U>. Capitalized terms used in this Agreement shall have the meanings
set forth in this Section 4, unless the context clearly requires a different meaning.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">6.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-size: 10pt">&ldquo;<B><I>Base Salary</I></B>&rdquo; means the greater of (a) if applicable, the monthly salary
of the Executive in effect immediately prior to the Change of Control, or (b) the monthly salary of the Executive in effect immediately
prior to the Termination Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">6.3<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-size: 10pt">&ldquo;<B><I>Cause</I></B>&rdquo; means: </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the Executive willfully failed to follow the lawful written directions of
the Board of Directors of the Company (the &ldquo;<B><I>Board</I></B>&rdquo;) or Executive&rsquo;s immediate superior; provided that no
termination for such Cause shall occur unless the Executive: (i) has been provided with notice, specifying such willful failure in reasonable
detail, of the Company&rsquo;s intention to terminate the Executive for Cause; and (ii) has failed to cure or correct such willful failure
within thirty (30) days of receiving such notice; </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the Executive engaged in gross misconduct, or gross incompetence which is
materially detrimental to the Company; provided that no termination for such Cause shall occur unless the Executive: (i) has been provided
with notice, specifying such gross misconduct or gross incompetence in reasonable detail, of the Company&rsquo;s intention to terminate
the Executive for Cause; and (ii) has failed to cure or correct such gross misconduct within thirty (30) days of receiving such notice;
</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the Executive willfully failed to comply in a material respect with the
Employee Invention Assignment &amp; Confidentiality Agreement, the Company&rsquo;s share dealing code, the Executive&rsquo;s non-competition
agreement, or any other reasonable policies of the Company where non-compliance would be materially detrimental to the Company; provided
that no termination for such Cause shall occur unless the Executive: (i) has been provided with notice of the Company&rsquo;s intention
to terminate the Executive for such Cause, and (ii) has failed to cure or correct such willful failure within thirty (30) days of receiving
such notice, provided that such notice and cure period requirements shall not apply in the event that such non-compliance is of a nature
that it is unable to be remedied; or</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The Executive is convicted of a felony or intentional crime of moral turpitude
(excluding drunk driving unless combined with other aggravating circumstances or offenses) or commission of a fraud that the Company reasonably
believes would have a material adverse effect on the Company.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">6.4<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-size: 10pt">&ldquo;<B><I>Change of Control</I></B>&rdquo; means: </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">any &ldquo;person&rdquo; (as such term is used in Sections 13(d) and 14(d)
of the Securities Exchange Act of 1934, as amended (the &ldquo;<B><I>Exchange Act</I></B>&rdquo;)) becomes the &ldquo;beneficial owner&rdquo;
(as defined in Rule 13d-3 promulgated under the Exchange Act), directly or indirectly, of securities of the Company representing fifty
(50%) percent or more of (i) the outstanding shares of common stock of the Company, or (ii) the combined voting power of the Company&rsquo;s
outstanding securities;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the Company is party to a merger or consolidation, or series of related
transactions, which results in the voting securities of the Company outstanding immediately prior thereto failing to continue to represent
(either by remaining outstanding or by being converted into voting securities of the surviving entity), directly or indirectly, at least
fifty (50%) percent of the combined voting power of the voting securities of the Company or such surviving entity outstanding immediately
after such merger or consolidation;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the sale or disposition of all or substantially all of the Company&rsquo;s
assets, or consummation of any transaction, or series of related transactions, having similar effect (other than to a subsidiary of the
Company); </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">a change in the composition of the Board within any consecutive two-year
period, as a result of which fewer than a majority of the directors are Incumbent Directors. &ldquo;Incumbent Directors&rdquo; shall mean
directors who either (i) were directors of the Company as of the effective date of this Agreement, or (ii) are elected, or nominated for
election, to the Board with the affirmative votes of a least a majority of those directors whose election or nomination was not in connection
with an actual or threatened proxy contest related to the election of directors to the Company; or</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the dissolution or liquidation of the Company. </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">6.5<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-size: 10pt">&ldquo;<B><I>Company</I></B>&rdquo; shall mean AUTHID INC. and, following a Change of Control, any
Successor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">6.6<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-size: 10pt">&ldquo;<B><I>Company Plans</I></B>&rdquo; shall mean the Company&rsquo;s 2021 Equity Incentive Plan
and any employee equity plan that replaces or supplements such plan, as well as any grant of stock options, restricted stock, stock appreciation
rights, stock award, or stock purchase offer, which may be made to Executive outside of any such plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">6.7<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-size: 10pt">&ldquo;<B><I>Involuntary Termination</I></B>&rdquo; means: </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">any termination without Cause of the employment of the Executive by the
Company; or</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">any resignation by Executive for Good Reason where such resignation occurs
within one hundred twenty (120) days following the occurrence of such Good Reason.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Notwithstanding the foregoing, the term &ldquo;Involuntary
Termination&rdquo; shall not include any termination of the employment of the Executive: (1) by the Company for Cause; (2) by the Company
as a result of the Permanent Disability of the Executive; (3)&nbsp;as a result of the death of the Executive; (4) as a result of the voluntary
termination of employment by the Executive for any reason other than Good Reason, or (5) that would qualify as a Termination Upon Change
of Control hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">6.8<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-size: 10pt">&ldquo;<B><I>Good Reason</I></B>&rdquo; means the occurrence of any of the following conditions,
without the Executive&rsquo;s written consent:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Any act, set of facts or omissions with respect to the Executive that would,
as a matter of applicable law, constitute a constructive termination of the Executive.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The assignment to the Executive of a title, position, responsibilities or
duties that is not a &ldquo;Substantive Functional Equivalent&rdquo; to the title, position, responsibilities or duties which the Executive
had immediately prior to such assignment (including, as relevant, immediately prior to the public announcement of the Change of Control).</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">A material reduction in the Executive&rsquo;s Base Salary or, if applicable,
target bonus opportunity (subject to applicable performance requirements with respect to the actual amount of bonus compensation earned
similar to the applicable performance requirements currently in effect), and in the event of a Change of Control, as compared to Executive&rsquo;s
Base Salary and target bonus opportunity in effect immediately prior to the public announcement of the Change of Control; provided, however,
that this clause (c) shall not apply in the event of a reduction in the Executive&rsquo;s Base Salary or, if applicable, target bonus
opportunity as part of a Company-wide or executive team-wide cost-cutting measure or Company-wide or executive team-wide cutback as a
result of overall Company performance. </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The failure of the Company (i) to continue to provide the Executive an opportunity
to participate in any benefit or compensation plans provided to employees who hold positions with the Company comparable to the Executive&rsquo;s
position, (ii) to provide the Executive all other fringe benefits (or the equivalent) in effect for the benefit of any employee group
which includes any employee who hold a position with the Company comparable to the Executive&rsquo;s position, where in the event of a
Change of Control, such comparison shall be made relative to the time immediately prior to the public announcement of such Change of Control);
or (iii) continue to provide director&rsquo;s and officers&rsquo; insurance.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">A material breach of this Agreement by the Company, including, in the event
of a Change of Control, failure of the Company to obtain the consent of a Successor to perform all of the obligations of the Company under
this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Executive must first give the Company an opportunity
to cure any of the foregoing within thirty (30) days following delivery to the Company of a written explanation specifying the specific
basis for Executive&rsquo;s belief that Executive is entitled to terminate employment for Good Reason, and Executive terminates employment
with the Company not later than (30) days following the Company&rsquo;s failure to cure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">6.9<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-size: 10pt">&ldquo;<B><I>Permanent Disability</I></B>&rdquo; means that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the Executive has been incapacitated by bodily injury, illness or disease
so as to be prevented thereby from engaging in the performance of the Executive&rsquo;s duties;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">such total incapacity shall have continued for a period of six consecutive
months; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">such incapacity will, in the opinion of a qualified physician, be permanent
and continuous during the remainder of the Executive&rsquo;s life.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">6.10<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-size: 10pt">&ldquo;<B><I>Substantive Functional Equivalent</I></B>&rdquo; means that the Executive&rsquo;s position
must:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">be in a substantive area of the Executive&rsquo;s competence (e.g., finance
or executive management) and not materially different from the position occupied immediately prior;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">allow the Executive to serve in a role and perform duties functionally equivalent
to those performed immediately prior; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">not otherwise constitute a material, adverse change in authority, title,
status, responsibilities or duties from those of the Executive immediately prior, causing the Executive to be of materially lesser rank
or responsibility, including requiring the Executive to report to a person other than the Board.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">6.11<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-size: 10pt">&ldquo;<B><I>Successor</I></B>&rdquo; means any successor in interest to, or assignee of, substantially
all of the business and assets of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">6.12<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-size: 10pt">&ldquo;<B><I>Termination Date</I></B>&rdquo; means the date of the termination of the Executive&rsquo;s
employment with the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">6.13<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-size: 10pt">&ldquo;<B><I>Termination Upon Change of Control</I></B>&rdquo; means: </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">any termination of the employment of the Executive by the Company without
Cause during the period commencing on or after the date that the Company first publicly announces a definitive agreement that results
in a Change of Control (even though still subject to approval by the Company&rsquo;s stockholders and other conditions and contingencies,
but provided that the Change of Control actually occurs) and ending on the date which is twelve (12) months following the Change of Control;
or</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">any resignation by Executive for Good Reason where (i) such Good Reason
occurs during the period commencing on or after the date that the Company first publicly announces a definitive agreement that results
in a Change of Control (even though still subject to approval by the Company&rsquo;s stockholders and other conditions and contingencies,
but provided that the Change of Control actually occurs) and ending on the date which is twelve (12) months following the Change of Control,
and (ii) such resignation occurs at or after such Change in Control and in any event within twelve (12) months following the expiration
of any Company cure period.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Notwithstanding the foregoing, the term &ldquo;Termination
Upon Change of Control&rdquo; shall not include any termination of the employment of the Executive: (1) by the Company for Cause; (2)
by the Company as a result of the Permanent Disability of the Executive; (3)&nbsp;as a result of the death of the Executive; or (4) as
a result of the voluntary termination of employment by the Executive for any reason other than Good Reason.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-transform: uppercase">7.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></FONT><FONT STYLE="font-size: 10pt"><U>EXCLUSIVE REMEDY</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">7.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-size: 10pt"><U>No Other Benefits Payable</U>. The Executive shall be entitled to no other termination, severance
or change of control compensation, benefits, or other payments from the Company as a result of any termination with respect to which the
payments and benefits described in Section 2 have been provided to the Executive, except as expressly set forth in this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">7.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-size: 10pt"><U>No Limitation of Regular Benefit Plans</U>. Except as may be provided elsewhere in this Agreement,
this Agreement is not intended to and shall not affect, limit or terminate any plans, programs or arrangements of the Company that are
regularly made available to a significant number of employees or officers of the Company, including, without limitation, the Company&rsquo;s
stock option plans.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">7.3<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Release of Claims</U>. The payment of the benefits described in Sections 3 and 4 of this Agreement
is conditioned upon the delivery by the Executive to the Company of a signed and effective general release of claims as provided by the
Company in the form attached hereto as Exhibit 1; provided, however, that the Executive shall not be required to release any rights the
Executive may have to be indemnified by the Company or as otherwise provided under this Agreement or to or under any Shares then-owned
by Executive at the time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">7.4<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Noncumulation of Benefits</U>. The Executive may not cumulate cash severance payments, stock option
vesting and exercisability and restricted stock vesting under this Agreement, any other written agreement with the Company and/or another
plan or policy of the Company. If the Executive has any other binding written agreement with the Company which provides that, upon a Change
of Control or Termination Upon a Change of Control or Involuntary Termination, the Executive shall receive termination, severance or similar
benefits, then no benefits shall be received by Executive under this Agreement unless, prior to payment or receipt of benefits under this
Agreement, the Executive waives Executive&rsquo;s rights to all such other benefits, in which case this Agreement shall supersede any
such written agreement with respect to such other benefits.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-transform: uppercase">8.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></FONT><FONT STYLE="font-size: 10pt"><U>ARBITRATION</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">8.1<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Disputes Subject to Arbitration</U>. Any claim, dispute or controversy arising out of this Agreement
(other than claims relating to misuse or misappropriation of the intellectual property of the Company), the interpretation, validity or
enforceability of this Agreement or the alleged breach thereof shall be submitted by the parties to binding arbitration by a sole arbitrator
under the rules of the American Arbitration Association; provided, however, that (a) the arbitrator shall have no authority to make any
ruling or judgment that would confer any rights with respect to the trade secrets, confidential and proprietary information or other intellectual
property of the Company upon the Executive or any third party; and (b) this arbitration provision shall not preclude the Company from
seeking legal and equitable relief from any court having jurisdiction with respect to any disputes or claims relating to or arising out
of the misuse or misappropriation of the Company&rsquo;s intellectual property. Judgment may be entered on the award of the arbitrator
in any court having jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">8.2<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Costs of Arbitration</U>. All costs of arbitration, including reasonable attorney&rsquo;s fees
of the Executive, will be borne by the Company, except that if the Executive initiates arbitration and the arbitrator finds the Executive&rsquo;s
claims to be frivolous the Executive shall be responsible for their own costs and attorneys&rsquo; fees. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">8.3<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-size: 10pt"><U>Site of Arbitration</U>. The site of the arbitration proceeding shall be in Austin, Texas.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-transform: uppercase">9.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></FONT><FONT STYLE="font-size: 10pt"><U>NOTICES</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For purposes of this Agreement, notices and all
other communications provided for in the Agreement shall be in writing and shall be deemed to have been duly given when delivered or five
(5) business days after being mailed, return receipt requested, as follows: (a) if to the Company, attention: General Counsel, at the
Company&rsquo;s address at 1624 Market St. Ste 226, Unit 51767, Denver, Colorado 80202-1559 or legal@authid.ai and, (b) if to the Executive,
at the address indicated below or such other address specified by the Executive in writing to the Company. Either party may provide the
other with notices of change of address, which shall be effective upon receipt.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="text-transform: uppercase">10.
</FONT><U>MISCELLANEOUS PROVISIONS</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">10.1<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Heirs and Representatives of the Executive; Successors and Assigns of the Company</U>. This Agreement shall be binding upon
and shall inure to the benefit of and be enforceable by the Executive&rsquo;s personal and legal representatives, executors, administrators,
successors, heirs, distributees, devises and legatees. This Agreement shall be binding upon and inure to the benefit of and be enforceable
by the successors and assigns of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">10.2<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Amendment and Waiver</U>. No provision of this Agreement shall be modified, amended, waived or discharged unless the modification,
amendment, waiver or discharge is agreed to in writing, specifying such modification, amendment, waiver or discharge, and signed by the
Executive and by an authorized officer of the Company (other than the Executive). No waiver by either party of any breach of, or of compliance
with, any condition or provision of this Agreement by the other party shall be considered a waiver of any other condition or provision
or of the same condition or provision at another time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">10.3<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Withholding Taxes</U>. All payments made under this Agreement shall be subject to deduction of all federal, state, local and
other taxes required to be withheld by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">10.4<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Severability</U>. The invalidity or unenforceability of any provision or provisions of this Agreement shall not affect the validity
or enforceability of any other provision hereof, which shall remain in full force and effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">10.5<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Choice of Law</U>. The validity, interpretation, construction and performance of this Agreement shall be governed by the laws
of the State of Illinois, without regard to where the Executive has their residence or principal office or where they perform their duties
hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">10.6<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>No Duty to Mitigate</U>. The Executive is not required to seek alternative employment following termination, and payments called
for under this Agreement will not be reduced by earnings from any other source.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">10.7<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Section 409A of the Code</U>. The intent of the parties is that payments and benefits under this Agreement comply with Section
409A of the Code and the Treasury Regulations and guidance promulgated thereunder (&ldquo;<B>Section 409A</B>&rdquo;), to the extent subject
thereto, and accordingly, to the maximum extent permitted, this letter shall be interpreted and administered to be in compliance therewith.
Notwithstanding anything contained herein to the contrary, Executive shall not be considered to have terminated employment with the Company
for purposes of any provision in this Agreement providing for the payment of any amounts or benefits subject to Section 409A upon or following
a termination of employment until Executive would be considered to have incurred a &ldquo;separation from service&rdquo; from the Company
within the meaning of Section 409A and this Agreement shall be interpreted consistently therewith. Without limiting the foregoing, and
notwithstanding anything to the contrary contained herein, to the extent (a) any payments or benefits to which Executive becomes entitled
under this Agreement, or under any agreement or plan referenced herein, in connection with Executive&rsquo;s termination of employment
with the Company constitute deferred compensation subject to Section 409A of the Code and (b) Executive is deemed at the time of such
termination of employment to be a &ldquo;specified employee&rdquo; under Section 409A of the Code, then such payments shall not be made
or commence until the earliest of (i) the expiration of the six (6)-month period measured from the date of Executive&rsquo;s &ldquo;separation
from service&rdquo; (as such term is at the time defined in Treasury Regulations under Section 409A of the Code) from the Company; or
(ii) the date of Executive&rsquo;s death following such separation from service; provided, however, that such deferral shall only be effected
to the extent required to avoid adverse tax treatment to Executive, including (without limitation) the additional twenty percent (20%)
tax for which Executive would otherwise be liable under Section 409A(a)(1)(B) of the Code in the absence of such deferral. Upon the expiration
of the applicable deferral period, any payments which would have otherwise been made during that period (whether in a single sum or in
installments) in the absence of this paragraph shall be paid to Executive or Executive&rsquo;s beneficiary in one lump sum (without interest).
Any termination of Executive&rsquo;s employment is intended to constitute a &ldquo;separation from service&rdquo; as such term is defined
in Treasury Regulation Section 1.409A-1. It is intended that each installment of the payments provided hereunder constitute separate and
distinct &ldquo;payments&rdquo; for purposes of Section 1.409A of the Code. It is further intended that payments hereunder satisfy, to
the greatest extent possible, the exemption from the application of Code Section 409A (and any state law of similar effect) provided under
Treasury Regulation Section 1.409A-1(b)(4) (as a &ldquo;short-term deferral&rdquo;). The Company makes no representation that any or all
of the payments described or referenced in this letter will be exempt from or comply with Section 409A and makes no undertaking to preclude
Section 409A from applying to any such payment, and Company&rsquo;s only obligation is to comply with its obligations set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">10.8<FONT STYLE="font-family: Times New Roman, Times, Serif">
</FONT><U>Entire Agreement</U>. This Agreement represents the entire agreement and understanding between the parties as to the subject
matter herein (whether oral or written and whether express or implied). The Executive hereby acknowledges, represents and warrants that
they have been individually represented by counsel in negotiating and signing this agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-variant: small-caps"><B><I>[SIGNATURE
PAGE FOLLOWS]</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-variant: small-caps">In Witness
Whereof</FONT>, each of the parties has executed this Agreement, in the case of the Company, by its duly authorized officer, as of the
day and year first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in"><FONT STYLE="font-variant: small-caps"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in"><FONT STYLE="font-variant: small-caps"><B></B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font: small-caps 10pt Times New Roman, Times, Serif"><B>Executive</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 36%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RHONIEL A. DAGURO</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 27.35pt"><FONT STYLE="font-size: 10pt">846 Farm Drive </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">West Chicago, IL 60185</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font: small-caps 10pt Times New Roman, Times, Serif"><B>authID Inc.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thomas L. Thimot, CEO</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in"><FONT STYLE="font-variant: small-caps"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>EXHIBIT 1</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>RELEASE OF CLAIMS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This General Release of all
Claims (this &ldquo;<U>Release</U>&rdquo;) is entered into on [&#9679;], by and between <B>AUTHID INC.</B>, a Delaware corporation (the
&ldquo;<U>Company</U>&rdquo;), and <B>RHONIEL A. DAGURO</B> (the &ldquo;<U>Executive</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In accordance with Section
7.3 of the Executive Retention Agreement by and between the Company and the Executive, effective __________, 2023 (the &ldquo;<U>Retention
Agreement</U>&rdquo;), in consideration of the payments and benefits to which the Executive is entitled pursuant to the Retention Agreement
subject to the execution and non-revocation of this Release, the Executive agrees as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>General
Release and Waiver of Claims</U>.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">o</TD><TD STYLE="text-align: justify"><I>Release</I>. The Executive and each of the Executive&rsquo;s respective heirs, executors, administrators,
representatives, agents, successors and assigns (collectively, the &ldquo;<U>Releasors</U>&rdquo;) hereby irrevocably and unconditionally
release and forever discharge the Company and each of its subsidiaries and affiliates and each of their respective officers, employees,
directors, managers, shareholders and agents (&ldquo;<U>Releasees</U>&rdquo;) from any and all claims, actions, causes of action, rights,
judgments, obligations, damages, demands, accountings or liabilities of whatever kind or character (collectively, &ldquo;<U>Claims</U>&rdquo;),
including, without limitation, any Claims under any federal, state, local or foreign law, that the Releasors may have or in the future
may possess, arising out (i) of the Executive&rsquo;s employment relationship with and service as an employee, officer, manager or director
of the Company, and the termination of such relationship or service and (ii) any event, condition, circumstance or obligation that occurred,
existed or arose on or prior to the date hereof, physical injuries excepted; <I>provided, however</I>, that notwithstanding anything else
herein to the contrary, this Release shall not affect: the obligations of the Company to pay the amounts due and owing to Executive on
the Termination Date or other obligations that, in each case, by their terms, are to be performed after the date hereof by the Company;
any indemnification or similar rights the Executive has as a current or former officer, manager or director of the Company, including,
without limitation, any and all rights thereto referenced in the Company&rsquo;s governance documents or any rights with respect to &ldquo;directors&rsquo;
and officers&rsquo;&rdquo; insurance policies; and the Executive&rsquo;s right to reimbursement of business expenses; any ownership Executive
holds in Company Shares and other vested or acquired equity, and rights existing thereunder.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">o</TD><TD STYLE="text-align: justify"><I>Specific Release of ADEA Claims</I>. The Releasors hereby unconditionally release and forever discharge
the Releasees from any and all Claims that the Releasors may have as of the date the Executive signs this Release arising under the Federal
Age Discrimination in Employment Act of 1967, as amended, and the applicable rules and regulations promulgated thereunder (&ldquo;<U>ADEA</U>&rdquo;).
By signing this Release, the Executive hereby acknowledges and confirms the following: (i)&nbsp;the Executive was advised by the Company
in connection with their termination to consult with an attorney of their choice prior to signing this Release and to have such attorney
explain to the Executive the terms of this Release, including, without limitation, the terms relating to the Executive&rsquo;s release
of claims arising under ADEA, and the Executive has in fact consulted with an attorney; (ii)&nbsp;the Executive was given a period of
not fewer than twenty-one (21) calendar days to consider the terms of this Release and to consult with an attorney of their choosing with
respect thereto; and (iii)&nbsp;the Executive knowingly and voluntarily accepts the terms of this Release. The Executive also understands
that they have seven&nbsp;(7) calendar days following the date on which they sign this Release within which to revoke the release contained
in this paragraph, by providing the Company a written notice of their revocation of the release and waiver contained in this paragraph.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">o</TD><TD STYLE="text-align: justify"><I>Release of All Claims</I>. The Executive acknowledges, understands and agrees that they may later discover
Claims or facts in addition to or different from those which they now knows or believes to be true with respect to the subject matters
of this Release, but that it is nevertheless their intention by signing this Release to fully, finally and forever release any and all
Claims whether now known or unknown, suspected or unsuspected, which now exist, may exist, or previously have existed as set forth herein.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.75in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Executive agrees and acknowledges that the released claims extend to and include unknown and unsuspected claims. In furtherance of the Executive&rsquo;s intent, the release in this Release shall remain in full and complete effect notwithstanding the discovery or existence of any additional, contrary, or different facts.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>No Assignment</I>.&nbsp;&nbsp;The Executive represents and warrants that they have not assigned any of the Claims being released under this Release.</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Proceedings</U>.
The Executive has not filed, and agrees not to initiate or cause to be initiated on their behalf, any complaint, charge, claim or proceeding
against the Releasees before any local, state or federal agency, court or other body, other than in respect of any matter described in
the proviso to Section 1(a) of this Release (each, individually, a &ldquo;<U>Proceeding</U>&rdquo;), and agrees not to participate voluntarily
in any Proceeding. The Executive waives any right they have may have to benefit in any manner from any relief (whether monetary or otherwise)
arising out of any Proceeding.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Remedies</U>.
The Executive understands that by entering into this Release they have will be limiting the availability of certain remedies that they
have may have against the Company and limiting also their ability to pursue certain claims against the Company.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Severability
Clause</U>. In the event any provision or part of this Release is found to be invalid or unenforceable, only that particular provision
or part so found, and not the entire Release, will be inoperative.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Non-admission</U>.
Nothing contained in this Release will be deemed or construed as an admission of wrongdoing or liability on the part of the Company.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Governing
Law</U>. All matters affecting this Release, including the validity thereof, are to be governed by, and interpreted and construed in
accordance with, the laws of the State of Illinois applicable to contracts executed in and to be performed in that State.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Capitalized
Terms</U>. Capitalized terms used but not defined herein have the meanings ascribed to them in the Retention Agreement.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>THE EXECUTIVE ACKNOWLEDGES THAT THEY HAVE READ
THIS RELEASE AND THAT THEY FULLY KNOW, UNDERSTAND AND APPRECIATE ITS CONTENTS, AND THAT THEY HEREBY EXECUTES THE SAME AND MAKES THIS AGREEMENT
AND THE RELEASE AND AGREEMENTS PROVIDED FOR HEREIN VOLUNTARILY AND OF THEIR OWN FREE WILL.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the Executive
has executed this Release on the date first set forth below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXECUTIVE:</B></FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RHONIAL A. DAGURO</B></FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ACKNOWLEDGED AND AGREED</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AUTHID INC.</B></FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify; width: 36%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Its:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT C</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EMPLOYEE INVENTION ASSIGNMENT AND CONFIDENTIALITY
AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: justify"><B>THIS EMPLOYEE INVENTION ASSIGNMENT
AND CONFIDENTIALITY AGREEMENT </B>is entered into as of the date of signature below, between I the undersigned <B>RHONIEL A. DAGURO <I>(&ldquo;Executive&rdquo;)</I></B>
with an address at 846 Farm Drive, West Chicago, IL 60185 and <B>authID INC.</B>, a Delaware corporation with a place of business at 1385
S. Colorado Blvd. Building A, Suite 322, Denver, CO 80222, (the <B><I>&ldquo;Company&rdquo;</I></B>).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">WHEREAS, I have agreed to be an employee of the
Company or one of its affiliated entities (collectively referred to herein as the &ldquo;<B><I>Company</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">IN CONSIDERATION OF, and as a condition of my
employment with the Company (the receipt and sufficiency of which I hereby acknowledge) I hereby represent to, and agree with the Company
as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></B><B><FONT STYLE="font-size: 10pt"><U>Purpose of Agreement</U>.</FONT></B><FONT STYLE="font-size: 10pt"> I understand that it
is critical for the Company to preserve and protect its rights in <B><I>&ldquo;Inventions&rdquo;</I></B> (as defined in Section 2 below),
its <B><I>&ldquo;Confidential Information&rdquo;</I></B> (as defined in Section&nbsp;7 below) and in all related intellectual property
rights. Accordingly, I am entering into this Employee Invention Assignment and Confidentiality Agreement (this <B><I>&ldquo;Agreement&rdquo;</I></B>)
as a condition of my employment with the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></B><B><FONT STYLE="font-size: 10pt"><U>Disclosure of Inventions</U>.</FONT></B><FONT STYLE="font-size: 10pt"> I will promptly
disclose in confidence to the Company all inventions, improvements, designs, original works of authorship, formulas, processes, compositions
of matter, computer software programs, databases, mask works and trade secrets (the <B><I>&ldquo;Inventions&rdquo;</I></B>) that I make
or conceive or first reduce to practice or create, either alone or jointly with others, during the period of my employment, whether or
not in the course of my employment, and whether or not such Inventions are patentable, copyrightable or protectable as trade secrets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></B><B><FONT STYLE="font-size: 10pt"><U>Work for Hire</U>.</FONT></B><FONT STYLE="font-size: 10pt"> I acknowledge and agree that
any copyrightable works prepared by me within the scope of my employment, including for the avoidance of doubt any such works prepared
prior to the date hereof are &ldquo;works made for hire&rdquo; under the Copyright Law of the United States and that the Company will
be considered the author and owner of such copyrightable works. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>4.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></B><B><FONT STYLE="font-size: 10pt"><U>Assignment of Inventions.</U></FONT></B><FONT STYLE="font-size: 10pt"> I agree that all
Inventions that (i)&nbsp;have been or are developed using equipment, supplies, facilities, Confidential Information, or trade secrets
of the Company, (ii)&nbsp;result from work performed by me for the Company, or (iii)&nbsp;relate to the Company&rsquo;s business or current
or anticipated research and development (the <B><I>&ldquo;Assigned Inventions&rdquo;</I></B>), will be the sole and exclusive property
of the Company and are hereby irrevocably assigned by me to the Company. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>5.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></B><B><FONT STYLE="font-size: 10pt"><U>Assignment of Other Rights; Moral Rights</U>. </FONT></B><FONT STYLE="font-size: 10pt">In
addition to the foregoing assignment of Assigned Inventions to the Company, I hereby irrevocably transfer and assign to the Company: (i)&nbsp;all
worldwide patents, patent applications, copyrights, mask works, trade secrets and other intellectual property rights, including but not
limited to rights in databases, in any Assigned Inventions, along with any registrations of or applications to register such rights; and
(ii)&nbsp;any and all &ldquo;Moral Rights&rdquo; (as defined below) that I may have in or with respect to any Assigned Inventions. I also
hereby forever waive and agree never to assert any and all Moral Rights I may have in or with respect to any Assigned Inventions, even
after termination of my work on behalf of the Company. <B><I>&ldquo;Moral Rights&rdquo;</I></B> mean any rights to claim authorship of
or credit on an Assigned Invention, to object to or prevent the modification or destruction of any Assigned Inventions, or to withdraw
from circulation or control the publication or distribution of any Assigned Inventions, and any similar right, existing under judicial
or statutory law of any country or subdivision thereof in the world, or under any treaty, regardless of whether or not such right is denominated
or generally referred to as a &ldquo;moral right.&rdquo; </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>6.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></B><B><FONT STYLE="font-size: 10pt"><U>Assistance</U>.</FONT></B><FONT STYLE="font-size: 10pt"> I agree to assist the Company
in every proper way, at the Company&rsquo;s cost, to obtain for the Company and enforce patents, copyrights, mask work rights, trade secret
rights and other legal protections for the Company&rsquo;s Assigned Inventions in any and all countries. I will execute any documents
that the Company may reasonably request for use in obtaining or enforcing such patents, copyrights, mask work rights, trade secrets and
other legal protections. My obligations under this paragraph will continue beyond the termination of my employment with the Company, provided
that the Company will compensate me at a reasonable rate after such termination for time or expenses actually spent by me at the Company&rsquo;s
request on such assistance. I appoint the Secretary of the Company as my attorney-in-fact to execute documents on my behalf for this purpose.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>7.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></B><B><FONT STYLE="font-size: 10pt"><U>Confidential Information</U>.</FONT></B><FONT STYLE="font-size: 10pt"> I understand that
my employment by the Company creates a relationship of confidence and trust with respect to any non-public information that may be disclosed
to me by the Company and its officers, employees, shareholders or agents, whether orally, in writing, by computer or other medium, by
demonstration, by supply of samples and parts or in any other manner, or which is otherwise accessible to me, that relates to the business
of the Company or to the business of any parent, subsidiary, affiliate, customer or supplier of the Company including all information
received by the Company from third parties, which is subject to an obligation of confidentiality (the <B><I>&ldquo;Confidential Information&rdquo;</I></B>).
Such Confidential Information includes, but is not limited to, Assigned Inventions, computer programming and software, Company products
and services, systems, functionality, designs, hardware, parts, concepts, specifications, features, techniques, plans, marketing, sales,
performance, cost, pricing, supplier and customer information, data, tables, schedules, contracts and other information concerning the
Company and its customers. <FONT STYLE="background-color: white">Notwithstanding the foregoing, Confidential Information shall not include
information or material that (i)&nbsp;is publicly available or becomes publicly available through no action or fault of Executive, (ii)&nbsp;was
already in the Executive&rsquo;s possession or known to the Executive prior to being disclosed or provided to the Executive,&nbsp;</FONT><U>provided</U><FONT STYLE="background-color: white">,
that, the source of such information or material was not bound by a contractual, legal or fiduciary obligation of confidentiality to the
Company with respect thereto, or (iii)&nbsp;was or is obtained by the Executive from a third party, provided, that, such third party was
not bound by a contractual, legal or fiduciary obligation of confidentiality to the Company with respect to such information or material,.</FONT>
I hereby acknowledge that all such Confidential Information belongs to the Company (or the respective customer, supplier or third party,
which supplied it to the Company).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>8.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></B><B><FONT STYLE="font-size: 10pt"><U>Confidentiality</U>.</FONT></B><FONT STYLE="font-size: 10pt"> At all times, both during
my employment and after its termination (without limitation in point of time), I will keep and hold all such Confidential Information
in strict confidence and trust. I will not use or disclose any Confidential Information without the prior written consent of the Company,
except as may be necessary to perform my duties as an employee of the Company for the benefit of the Company. Upon termination of my employment
with the Company, I will promptly deliver to the Company all documents and materials of any nature pertaining to my work with the Company,
other than those of a personal nature (including as may be reasonably necessary for financial or legal advisors on such matters). I will
not take with me or retain any documents or materials or copies thereof containing any Confidential Information. I agree that I shall
at all times comply with the Company&rsquo;s Information Security Policy and Procedures (<B><I>&ldquo;ISPP&rdquo;</I></B>) from time to
time in force. <B>I acknowledge that breach of this ISPP policy or any other provision of this Agreement may be grounds for immediate
dismissal.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>9.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></B><B><FONT STYLE="font-size: 10pt"><U>No Breach of Agreement or Infringement</U>.</FONT></B><FONT STYLE="font-size: 10pt"> I
represent that my acceptance of the Company&rsquo;s offer of employment, performance of all the terms of this Agreement and my duties
as an employee of the Company will not so far as I am aware breach any invention assignment, proprietary information, confidentiality
or similar agreement with any other party, nor infringe the rights of any third party. I represent that I will not bring with me to the
Company or use in the performance of my duties for the Company any documents or materials or intangibles of a former employer or third
party that are not generally available or known to the public or in the industry or have not been legally transferred to the Company.
I acknowledge that the Company is relying upon my warranty, representation and acknowledgement in this paragraph in offering me employment.
</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>10.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></B><B><FONT STYLE="font-size: 10pt"><U>Notification</U>.</FONT></B><FONT STYLE="font-size: 10pt"> I hereby authorize the Company
to notify my actual or future employers of the terms of this Agreement and my responsibilities hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>11.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></B><B><FONT STYLE="font-size: 10pt"><U>Injunctive Relief</U>.</FONT></B><FONT STYLE="font-size: 10pt"> I understand that in the
event of a breach or threatened breach of this Agreement by me the Company may suffer irreparable harm and will therefore be entitled
to injunctive relief to enforce this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>12.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></B><B><FONT STYLE="font-size: 10pt"><U>Governing Law; Jurisdiction.</U></FONT></B><FONT STYLE="font-size: 10pt"> This Agreement
will be governed by and construed in accordance with the laws of the State of Illinois, without giving effect to that body of laws pertaining
to conflict of laws. I hereby submit to the jurisdiction of and consent to suit in the courts, Federal and State located in the State
of Illinois with respect to any matter or dispute arising out of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>13.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></B><B><FONT STYLE="font-size: 10pt"><U>Severability</U>. </FONT></B><FONT STYLE="font-size: 10pt">If any provision of this Agreement
is determined by any court or arbitrator of competent jurisdiction to be invalid, illegal or unenforceable in any respect, such provision
will be enforced to the maximum extent possible given the intent of the parties hereto. If such clause or provision cannot be so enforced,
such provision shall be stricken from this Agreement and the remainder of this Agreement shall be enforced as if such invalid, illegal
or unenforceable clause or provision had (to the extent not enforceable) never been contained in this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>14.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></B><B><FONT STYLE="font-size: 10pt"><U>Counterparts</U>.</FONT></B><FONT STYLE="font-size: 10pt"> This Agreement may be executed
in any number of counterparts, each of which when so executed and delivered will be deemed an original, and all of which together shall
constitute one and the same agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>15.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></B><B><FONT STYLE="font-size: 10pt"><U>Entire Agreement</U>.</FONT></B><FONT STYLE="font-size: 10pt"> This Agreement and the documents
referred to herein constitute the entire agreement and understanding of the parties with respect to the subject matter of this Agreement,
and supersede all prior understandings and agreements, whether oral or written, between or among the parties hereto with respect to the
specific subject matter hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>16.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></B><B><FONT STYLE="font-size: 10pt"><U>Amendment and Waivers.</U></FONT></B><FONT STYLE="font-size: 10pt"> This Agreement may
be amended only by a written agreement executed by each of the parties hereto. No amendment of or waiver of, or modification of any obligation
under this Agreement will be enforceable unless set forth in a writing signed by the party against which enforcement is sought. Any amendment
effected in accordance with this section will be binding upon all parties hereto and each of their respective successors and assigns.
No delay or failure to require performance of any provision of this Agreement shall constitute a waiver of that provision as to that or
any other instance. No waiver granted under this Agreement as to any one provision herein shall constitute a subsequent waiver of such
provision or of any other provision herein, nor shall it constitute the waiver of any performance other than the actual performance specifically
waived.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>17.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></B><B><FONT STYLE="font-size: 10pt"><U>Successors and Assigns; Assignment</U>.</FONT></B><FONT STYLE="font-size: 10pt"> Except
as otherwise provided in this Agreement, this Agreement, and the rights and obligations of the parties hereunder, will be binding upon
and inure to the benefit of their respective successors, assigns, heirs, executors, administrators and legal representatives. The Company
may assign any of its rights and obligations under this Agreement to any entity which is my employer. No other party to this Agreement
may assign, whether voluntarily or by operation of law, any of its rights and obligations under this Agreement, except with the prior
written consent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>[SIGNATURE PAGE FOLLOWS]</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --> -</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>18.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT></B><B><FONT STYLE="font-size: 10pt"><U>Further Assurances</U>.</FONT></B><FONT STYLE="font-size: 10pt"> The parties agree to execute
such further documents and instruments and to take such further actions as may be reasonably necessary to carry out the purposes and intent
of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>SIGNED AS OF THIS _____________________</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>RHONIEL A. DAGURO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>______________________________________</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">- 25 -</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>ea175837ex10-2_authid.htm
<DESCRIPTION>EXECUTIVE RETENTION AGREEMENT BETWEEN RHONIEL A. DAGURO AND AUTHID INC. DATED MARCH 23, 2023
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.2</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">EXECUTIVE RETENTION AGREEMENT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Executive Retention Agreement
(the &ldquo;<B><I>Agreement</I></B>&rdquo;) is made and entered into as of March 23 2023 by and between AUTHID INC., a Delaware corporation
(the &ldquo;<B><I>Company</I></B>&rdquo;), and RHONIAL A. DAGURO (the &ldquo;<B><I>Executive</I></B>&rdquo;).</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0">Recitals:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Executive is
a key employee of the Company who possesses valuable proprietary knowledge of the Company, its business and operations and the markets
in which the Company competes; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Company and the
Executive desire to enter into this Agreement to encourage the Executive to continue to devote the Executive&rsquo;s full attention and
dedication to the success of the Company, and to provide specified compensation and benefits to the Executive in the event of a Termination
Upon Change of Control or certain other terminations pursuant to the terms of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">NOW, THEREFORE, THE PARTIES HEREBY AGREE AS FOLLOWS:<BR>
<BR>
</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-transform: uppercase">1. </FONT><FONT STYLE="font-size: 10pt"><U>PURPOSE
AND TERM</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The purpose of this Agreement
is to provide specified compensation and benefits to the Executive in the event of (i) a Termination Upon Change of Control or (ii) an
Involuntary Termination. Subject to the terms of any applicable written employment agreement between Company and the Executive (as to
which Executive acknowledges no other such agreement exists as of the date hereof beyond the Employment Offer letter dated March 23, 2023),
either the Executive or Company may terminate the Executive&rsquo;s employment at any time for any reason, with or without notice. The
term of this Agreement shall be the period from the date set forth above until Executive&rsquo;s employment is terminated for any reason
or this Agreement is terminated by mutual agreement of the parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-transform: uppercase">2. </FONT><FONT STYLE="font-size: 10pt"><U>TERMINATION
GENERALLY</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">2.1 <FONT STYLE="font-size: 10pt"><U>Termination
of Employment Generally</U>. In the event the Executive&rsquo;s employment with the Company terminates, for any reason whatsoever including
death or disability the Executive shall be entitled to the benefits described in this Section 2.1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.1.1 <FONT STYLE="font-size: 10pt"><U>Accrued
Salary and Vacation</U>. All salary and accrued vacation earned through the Termination Date shall be paid to Executive on such Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.1.2 <FONT STYLE="font-size: 10pt"><U>Accrued
Bonus Payment</U>. The Executive shall receive a lump sum payment of any actual bonus amount to the extent that all the conditions for
payment of such bonus have been satisfied and any such bonus was earned and is unpaid on the Termination Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.1.3 <FONT STYLE="font-size: 10pt"><U>Expense
Reimbursement</U>. Within ten (10) days following submission to the Company of proper expense reports by the Executive, the Company shall
reimburse the Executive for all expenses incurred by the Executive, consistent with the Company&rsquo;s expense reimbursement policy in
effect prior to the incurring of each such expense, in connection with the business of the Company prior to the Termination Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="text-decoration: none; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="text-transform: uppercase">3. </FONT><FONT STYLE="font-size: 10pt"><U>TERMINATION
UPON CHANGE OF CONTROL</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">3.1 <FONT STYLE="font-size: 10pt"><U>Severance
Payment</U>. In the event of the Executive&rsquo;s Termination Upon Change of Control, the Executive shall be entitled to receive an amount
equal to twelve (12) months of the Executive&rsquo;s Base Salary and 100% of Executive&rsquo;s target annual bonus for the year in which
the Termination Date occurs (or, if greater, the target annual bonus in effect immediately prior to the Change of Control) which shall
be paid in a lump sum payment within ten (10) days following the Termination Date; provided, however, that if Section 409A of the Code
would otherwise apply to such cash severance payment, it instead shall be paid at such time as permitted by Section 409A of the Code.
The severance payment payable hereunder shall be reduced to the extent of the amount of any bonus payable to Executive upon a Change of
Control. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">3.2 <FONT STYLE="font-size: 10pt"><U>COBRA</U>.
The Company will reimburse Executive for the cost of continuation of health coverage for Executive and Executive&rsquo;s eligible dependents
pursuant to the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (&ldquo;<B><I>COBRA</I></B>&rdquo;) until the earlier
of (i) 12 months following the Termination Date, (ii) the date Executive is eligible for health coverage for Executive and Executive&rsquo;s
eligible dependents from a new employer or (iii) the date Executive and Executive&rsquo;s eligible dependents are no longer eligible for
COBRA; provided, however, if, at the time of the Termination Date, the Company determines that providing the COBRA reimbursement in this
paragraph would result in a violation of law or an excise tax to the Company, then the Company instead will pay a lump sum payment equal
to 150% of 12 months of Executive&rsquo;s estimated COBRA premiums, less applicable withholdings, within 10 days following the Termination
Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">3.3 <FONT STYLE="font-size: 10pt"><U>Equity
Compensation Acceleration</U>. Upon the Executive&rsquo;s Termination Upon Change of Control, the vesting and exercisability of all then
outstanding stock options and shares of restricted stock (or any other equity award, including, without limitation, stock appreciation
rights and restricted stock units) granted to the Executive under any Company Plans shall be accelerated as to 100% of the shares subject
to any such equity awards granted to the Executive. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">3.4 <FONT STYLE="font-size: 10pt"><U>Equity
Compensation Exercise</U>. Upon the Executive&rsquo;s Termination Upon Change of Control, the Exercise Period with respect to vested Shares,
under the Company Plans for the purposes of the Executive&rsquo;s stock options granted under the Company Plans shall be extended so as
to expire one (1) year from the date of Involuntary Termination or the remaining term of the relevant equity award, whichever is the lesser.
All other unvested Shares under any such grants or other equity awards not subject to acceleration under Section 3.3 shall lapse and no
longer be exercisable as of the date of Involuntary Termination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">3.5 <FONT STYLE="font-size: 10pt"><U>Indemnification</U>.
In the event of the Executive&rsquo;s Termination Upon Change of Control, (a) the Company shall continue to indemnify the Executive against
all claims related to actions arising prior to the termination of the Executive&rsquo;s employment to the fullest extent permitted by
law, and (b) if the Executive was covered by the Company&rsquo;s directors&rsquo; and officers&rsquo; insurance policy, or an equivalent
thereto, (the &ldquo;<B><I>D&amp;O Insurance Policy</I></B>&rdquo;) immediately prior to the Change of Control, the Company or its Successor
shall continue to provide coverage under a D&amp;O Insurance Policy for not less than twenty-four (24) months following the Executive&rsquo;s
Termination Upon Change of Control on substantially the same terms of the D&amp;O Insurance Policy in effect immediately prior to the
Change of Control. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="text-decoration: none; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="text-transform: uppercase">4. </FONT><FONT STYLE="font-size: 10pt"><U>INVOLUNTARY
TERMINATION</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">4.1 <FONT STYLE="font-size: 10pt"><U>Severance
Payment</U>. In the event of the Executive&rsquo;s Involuntary Termination, the Executive shall be entitled to receive an amount equal
to twelve (12) months of the Executive&rsquo;s Base Salary, which shall be paid according to the following schedule: (i) a lump sum payment
equal to one-fourth of such amount shall be payable within ten (10) days following the Termination Date, and (ii) one-fourth of such amount
shall be payable within ten (10) days of each of the three-month, six-month and nine-month anniversaries of the Termination Date (and
in each case no interest shall accrue on such amount); provided, however, that if Section 409A of the Code would otherwise apply to such
cash severance payment, it instead shall be paid at such time as permitted by Section 409A of the Code. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">4.2 <FONT STYLE="font-size: 10pt">Bonus
Payment. In addition to the foregoing severance payment, in the event of the Executive&rsquo;s Involuntary Termination, the Executive
shall be entitled to receive, within ten (10) days following the Executive&rsquo;s Involuntary Termination, a lump sum payment equal to
one hundred percent (100%) of any actual bonus amount earned with respect to a previous year to the extent that all the conditions for
payment of such bonus have been satisfied (excluding any requirement to be in employment with the Company as of a given date which is
after the Termination Date) and any such bonus was earned but is unpaid on the Termination Date. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">4.3 <FONT STYLE="font-size: 10pt"><U>COBRA</U>.
The Company will reimburse Executive for the cost of continuation of health coverage for Executive and Executive&rsquo;s eligible dependents
pursuant to COBRA until the earlier of (i)&nbsp;12 months following the Termination Date, (ii) the date Executive is eligible for health
coverage for Executive and Executive&rsquo;s eligible dependents from a new employer or (iii) the date Executive and Executive&rsquo;s
eligible dependents are no longer eligible for COBRA; provided, however, if, at the time of the Termination Date, the Company determines
that providing the COBRA reimbursement in this paragraph would result in a violation of law or an excise tax to the Company, then the
Company instead will pay a lump sum payment equal to 150% of 12 months of Executive&rsquo;s estimated COBRA premiums, less applicable
withholdings, within 10 days following the Termination Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">4.4 <FONT STYLE="font-size: 10pt"><U>Equity
Compensation Exercise</U>. Upon the Executive&rsquo;s Involuntary Termination, the Exercise Period with respect to vested Shares, under
the Company Plans for the purposes of the Executive&rsquo;s stock options granted under the Company Plans shall be extended so as to expire
one (1) year from the date of Involuntary Termination or the remaining term of the relevant equity award, whichever is the lesser. All
other unvested Shares under any such grants or other equity awards shall lapse and no longer be exercisable as of the date of Involuntary
Termination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">4.5 <FONT STYLE="font-size: 10pt"><U>Indemnification</U>.
In the event of the Executive&rsquo;s Involuntary Termination, (a) the Company shall continue to indemnify the Executive against all claims
related to actions arising prior to the Termination Date to the fullest extent permitted by law, and (b) if the Executive was covered
by the D&amp;O Insurance Policy immediately prior to the Termination Date, the Company shall continue to provide coverage under a D&amp;O
Insurance Policy for not less than twenty-four (24) months following the Executive&rsquo;s Involuntary Termination on substantially the
same terms of the D&amp;O Insurance Policy in effect immediately prior to the Termination Date. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-transform: uppercase">5. </FONT><FONT STYLE="font-size: 10pt"><U>FEDERAL
EXCISE TAX UNDER SECTION 280G</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">5.1 <FONT STYLE="font-size: 10pt"><U>Excise
Tax</U>. If (a) any amounts payable to the Executive under this Agreement or otherwise are characterized as excess parachute payments
pursuant to Section 4999 of the Internal Revenue Code of 1986, as amended (the &ldquo;<B><I>Code</I></B>&rdquo;), and (b) the Executive
thereby would be subject to any United States federal excise tax due to that characterization, then such amounts will either be (i)&nbsp;delivered
in full, or (ii) delivered to such lesser extent which would result in no portion of such amounts being subject to excise tax pursuant
to Section 4999 of the Code, whichever of the foregoing amounts, taking into account the applicable federal, state and local income taxes
and the excise tax imposed by Code Section 4999, results in Executive&rsquo;s receipt on an after-tax basis, of the greatest amounts,
notwithstanding that all or some portion of such amounts may be taxable under Code Section 4999. If a reduction in the amounts constituting
&ldquo;parachute payments&rdquo; is necessary so that no portion of such amounts are subject to the excise tax under Code Section 4999,
the reduction will occur in the following order: (i)&nbsp;reduction of the cash severance payments, which will occur in reverse chronological
order such that the cash payment owed on the latest date following the occurrence of the event triggering such excise tax will be the
first cash payment to be reduce; (ii) cancellation of accelerated vesting of equity awards which will occur in the reverse order of the
date of grant for such stock awards (i.e., the vesting of the most recently granted stock awards will be reduced first); and (iii) reduction
of continued employee benefits, which will occur in reverse chronological order such that the benefit owed on the latest date following
the occurrence of the event triggering such excise tax will be the first benefit to be reduced. If two or more equity awards are granted
on the same date, each award will be reduced on a pro-rata basis. Notwithstanding the foregoing, no such reduction or elimination shall
apply to any non-qualified deferred compensation amounts (within the meaning of Section 409A of the Code) to the extent such reduction
or elimination would accelerate or defer the timing of such payment in a manner that does not comply with Section 409A of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">5.2 <FONT STYLE="font-size: 10pt"><U>Calculation
by Independent Public Accountants</U>. Unless the Company and the Executive otherwise agree in writing, any calculation of the amount
of any excess parachute payments payable by the Executive shall be made in writing by the Company&rsquo;s independent public accountants
(the &ldquo;<B><I>Accountants</I></B>&rdquo;) whose conclusion shall be final and binding on the parties. For purposes of making such
calculations, the Accountants may rely on reasonable, good faith interpretations concerning the application of Sections 280G and 4999
of the Code. The Company and the Executive shall furnish to the Accountants such information and documents as the Accountants may reasonably
request in order to make the required calculations. The Company shall bear all fees and expenses the Accountants may charge in connection
with these services, but the engagement of the Accountants for this purpose shall be pursuant to an agreement between the Executive and
the Accountants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-transform: uppercase">6. </FONT><FONT STYLE="font-size: 10pt"><U>DEFINITIONS</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">6.1 <FONT STYLE="font-size: 10pt"><U>Capitalized
Terms Defined</U>. Capitalized terms used in this Agreement shall have the meanings set forth in this Section 4, unless the context clearly
requires a different meaning.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">6.2 <FONT STYLE="font-size: 10pt">&ldquo;<B><I>Base
Salary</I></B>&rdquo; means the greater of (a) if applicable, the monthly salary of the Executive in effect immediately prior to the Change
of Control, or (b) the monthly salary of the Executive in effect immediately prior to the Termination Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">6.3 <FONT STYLE="font-size: 10pt">&ldquo;<B><I>Cause</I></B>&rdquo;
means: </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the Executive willfully failed to follow the lawful written directions of
the Board of Directors of the Company (the &ldquo;<B><I>Board</I></B>&rdquo;) or Executive&rsquo;s immediate superior; provided that no
termination for such Cause shall occur unless the Executive: (i) has been provided with notice, specifying such willful failure in reasonable
detail, of the Company&rsquo;s intention to terminate the Executive for Cause; and (ii) has failed to cure or correct such willful failure
within thirty (30) days of receiving such notice; </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the Executive engaged in gross misconduct, or gross incompetence which is
materially detrimental to the Company; provided that no termination for such Cause shall occur unless the Executive: (i) has been provided
with notice, specifying such gross misconduct or gross incompetence in reasonable detail, of the Company&rsquo;s intention to terminate
the Executive for Cause; and (ii) has failed to cure or correct such gross misconduct within thirty (30) days of receiving such notice;
</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the Executive willfully failed to comply in a material respect with the
Employee Invention Assignment &amp; Confidentiality Agreement, the Company&rsquo;s share dealing code, the Executive&rsquo;s non-competition
agreement, or any other reasonable policies of the Company where non-compliance would be materially detrimental to the Company; provided
that no termination for such Cause shall occur unless the Executive: (i) has been provided with notice of the Company&rsquo;s intention
to terminate the Executive for such Cause, and (ii) has failed to cure or correct such willful failure within thirty (30) days of receiving
such notice, provided that such notice and cure period requirements shall not apply in the event that such non-compliance is of a nature
that it is unable to be remedied; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The Executive is convicted of a felony or intentional crime of moral turpitude
(excluding drunk driving unless combined with other aggravating circumstances or offenses) or commission of a fraud that the Company reasonably
believes would have a material adverse effect on the Company.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">6.4 <FONT STYLE="font-size: 10pt">&ldquo;<B><I>Change
of Control</I></B>&rdquo; means: </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">any &ldquo;person&rdquo; (as such term is used in Sections 13(d) and 14(d)
of the Securities Exchange Act of 1934, as amended (the &ldquo;<B><I>Exchange Act</I></B>&rdquo;)) becomes the &ldquo;beneficial owner&rdquo;
(as defined in Rule 13d-3 promulgated under the Exchange Act), directly or indirectly, of securities of the Company representing fifty
(50%) percent or more of (i) the outstanding shares of common stock of the Company, or (ii) the combined voting power of the Company&rsquo;s
outstanding securities;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the Company is party to a merger or consolidation, or series of related
transactions, which results in the voting securities of the Company outstanding immediately prior thereto failing to continue to represent
(either by remaining outstanding or by being converted into voting securities of the surviving entity), directly or indirectly, at least
fifty (50%) percent of the combined voting power of the voting securities of the Company or such surviving entity outstanding immediately
after such merger or consolidation;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the sale or disposition of all or substantially all of the Company&rsquo;s
assets, or consummation of any transaction, or series of related transactions, having similar effect (other than to a subsidiary of the
Company); </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">a change in the composition of the Board within any consecutive two-year
period, as a result of which fewer than a majority of the directors are Incumbent Directors. &ldquo;Incumbent Directors&rdquo; shall mean
directors who either (i) were directors of the Company as of the effective date of this Agreement, or (ii) are elected, or nominated for
election, to the Board with the affirmative votes of a least a majority of those directors whose election or nomination was not in connection
with an actual or threatened proxy contest related to the election of directors to the Company; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the dissolution or liquidation of the Company. </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">6.5 <FONT STYLE="font-size: 10pt">&ldquo;<B><I>Company</I></B>&rdquo;
shall mean AUTHID INC. and, following a Change of Control, any Successor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">6.6 <FONT STYLE="font-size: 10pt">&ldquo;<B><I>Company
Plans</I></B>&rdquo; shall mean the Company&rsquo;s 2021 Equity Incentive Plan and any employee equity plan that replaces or supplements
such plan, as well as any grant of stock options, restricted stock, stock appreciation rights, stock award, or stock purchase offer, which
may be made to Executive outside of any such plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">6.7 <FONT STYLE="font-size: 10pt">&ldquo;<B><I>Involuntary
Termination</I></B>&rdquo; means: </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">any termination without Cause of the employment of the Executive by the
Company; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">any resignation by Executive for Good Reason where such resignation occurs
within one hundred twenty (120) days following the occurrence of such Good Reason.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Notwithstanding the foregoing, the term &ldquo;Involuntary
Termination&rdquo; shall not include any termination of the employment of the Executive: (1) by the Company for Cause; (2) by the Company
as a result of the Permanent Disability of the Executive; (3)&nbsp;as a result of the death of the Executive; (4) as a result of the voluntary
termination of employment by the Executive for any reason other than Good Reason, or (5) that would qualify as a Termination Upon Change
of Control hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">6.8 <FONT STYLE="font-size: 10pt">&ldquo;<B><I>Good
Reason</I></B>&rdquo; means the occurrence of any of the following conditions, without the Executive&rsquo;s written consent:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Any act, set of facts or omissions with respect to the Executive that would,
as a matter of applicable law, constitute a constructive termination of the Executive.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The assignment to the Executive of a title, position, responsibilities or
duties that is not a &ldquo;Substantive Functional Equivalent&rdquo; to the title, position, responsibilities or duties which the Executive
had immediately prior to such assignment (including, as relevant, immediately prior to the public announcement of the Change of Control).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">A material reduction in the Executive&rsquo;s Base Salary or, if applicable,
target bonus opportunity (subject to applicable performance requirements with respect to the actual amount of bonus compensation earned
similar to the applicable performance requirements currently in effect), and in the event of a Change of Control, as compared to Executive&rsquo;s
Base Salary and target bonus opportunity in effect immediately prior to the public announcement of the Change of Control; provided, however,
that this clause (c) shall not apply in the event of a reduction in the Executive&rsquo;s Base Salary or, if applicable, target bonus
opportunity as part of a Company-wide or executive team-wide cost-cutting measure or Company-wide or executive team-wide cutback as a
result of overall Company performance. </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The failure of the Company (i) to continue to provide the Executive an opportunity
to participate in any benefit or compensation plans provided to employees who hold positions with the Company comparable to the Executive&rsquo;s
position, (ii) to provide the Executive all other fringe benefits (or the equivalent) in effect for the benefit of any employee group
which includes any employee who hold a position with the Company comparable to the Executive&rsquo;s position, where in the event of a
Change of Control, such comparison shall be made relative to the time immediately prior to the public announcement of such Change of Control);
or (iii) continue to provide director&rsquo;s and officers&rsquo; insurance.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">A material breach of this Agreement by the Company, including, in the event
of a Change of Control, failure of the Company to obtain the consent of a Successor to perform all of the obligations of the Company under
this Agreement.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Executive must first give the Company an opportunity
to cure any of the foregoing within thirty (30) days following delivery to the Company of a written explanation specifying the specific
basis for Executive&rsquo;s belief that Executive is entitled to terminate employment for Good Reason, and Executive terminates employment
with the Company not later than (30) days following the Company&rsquo;s failure to cure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">6.9 <FONT STYLE="font-size: 10pt">&ldquo;<B><I>Permanent
Disability</I></B>&rdquo; means that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the Executive has been incapacitated by bodily injury, illness or disease
so as to be prevented thereby from engaging in the performance of the Executive&rsquo;s duties;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">such total incapacity shall have continued for a period of six consecutive
months; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">such incapacity will, in the opinion of a qualified physician, be permanent
and continuous during the remainder of the Executive&rsquo;s life.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">6.10 <FONT STYLE="font-size: 10pt">&ldquo;<B><I>Substantive
Functional Equivalent</I></B>&rdquo; means that the Executive&rsquo;s position must:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">be in a substantive area of the Executive&rsquo;s competence (e.g., finance
or executive management) and not materially different from the position occupied immediately prior;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">allow the Executive to serve in a role and perform duties functionally equivalent
to those performed immediately prior; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">not otherwise constitute a material, adverse change in authority, title,
status, responsibilities or duties from those of the Executive immediately prior, causing the Executive to be of materially lesser rank
or responsibility, including requiring the Executive to report to a person other than the Board.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">6.11 <FONT STYLE="font-size: 10pt">&ldquo;<B><I>Successor</I></B>&rdquo;
means any successor in interest to, or assignee of, substantially all of the business and assets of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">6.12 <FONT STYLE="font-size: 10pt">&ldquo;<B><I>Termination
Date</I></B>&rdquo; means the date of the termination of the Executive&rsquo;s employment with the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">6.13 <FONT STYLE="font-size: 10pt">&ldquo;<B><I>Termination
Upon Change of Control</I></B>&rdquo; means: </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">any termination of the employment of the Executive by the Company without
Cause during the period commencing on or after the date that the Company first publicly announces a definitive agreement that results
in a Change of Control (even though still subject to approval by the Company&rsquo;s stockholders and other conditions and contingencies,
but provided that the Change of Control actually occurs) and ending on the date which is twelve (12) months following the Change of Control;
or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">any resignation by Executive for Good Reason where (i) such Good Reason
occurs during the period commencing on or after the date that the Company first publicly announces a definitive agreement that results
in a Change of Control (even though still subject to approval by the Company&rsquo;s stockholders and other conditions and contingencies,
but provided that the Change of Control actually occurs) and ending on the date which is twelve (12) months following the Change of Control,
and (ii) such resignation occurs at or after such Change in Control and in any event within twelve (12) months following the expiration
of any Company cure period.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Notwithstanding the foregoing, the term &ldquo;Termination
Upon Change of Control&rdquo; shall not include any termination of the employment of the Executive: (1) by the Company for Cause; (2)
by the Company as a result of the Permanent Disability of the Executive; (3)&nbsp;as a result of the death of the Executive; or (4) as
a result of the voluntary termination of employment by the Executive for any reason other than Good Reason.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-transform: uppercase">7. </FONT><FONT STYLE="font-size: 10pt"><U>EXCLUSIVE
REMEDY</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">7.1 <FONT STYLE="font-size: 10pt"><U>No
Other Benefits Payable</U>. The Executive shall be entitled to no other termination, severance or change of control compensation, benefits,
or other payments from the Company as a result of any termination with respect to which the payments and benefits described in Section
2 have been provided to the Executive, except as expressly set forth in this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">7.2 <FONT STYLE="font-size: 10pt"><U>No
Limitation of Regular Benefit Plans</U>. Except as may be provided elsewhere in this Agreement, this Agreement is not intended to and
shall not affect, limit or terminate any plans, programs or arrangements of the Company that are regularly made available to a significant
number of employees or officers of the Company, including, without limitation, the Company&rsquo;s stock option plans.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">7.3 <FONT STYLE="font-size: 10pt"><U>Release
of Claims</U>. The payment of the benefits described in Sections 3 and 4 of this Agreement is conditioned upon the delivery by the Executive
to the Company of a signed and effective general release of claims as provided by the Company in the form attached hereto as Exhibit 1;
provided, however, that the Executive shall not be required to release any rights the Executive may have to be indemnified by the Company
or as otherwise provided under this Agreement or to or under any Shares then-owned by Executive at the time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">7.4 <FONT STYLE="font-size: 10pt"><U>Noncumulation
of Benefits</U>. The Executive may not cumulate cash severance payments, stock option vesting and exercisability and restricted stock
vesting under this Agreement, any other written agreement with the Company and/or another plan or policy of the Company. If the Executive
has any other binding written agreement with the Company which provides that, upon a Change of Control or Termination Upon a Change of
Control or Involuntary Termination, the Executive shall receive termination, severance or similar benefits, then no benefits shall be
received by Executive under this Agreement unless, prior to payment or receipt of benefits under this Agreement, the Executive waives
Executive&rsquo;s rights to all such other benefits, in which case this Agreement shall supersede any such written agreement with respect
to such other benefits.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-transform: uppercase">8. </FONT><FONT STYLE="font-size: 10pt"><U>ARBITRATION</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">8.1 <FONT STYLE="font-size: 10pt"><U>Disputes
Subject to Arbitration</U>. Any claim, dispute or controversy arising out of this Agreement (other than claims relating to misuse or misappropriation
of the intellectual property of the Company), the interpretation, validity or enforceability of this Agreement or the alleged breach thereof
shall be submitted by the parties to binding arbitration by a sole arbitrator under the rules of the American Arbitration Association;
provided, however, that (a) the arbitrator shall have no authority to make any ruling or judgment that would confer any rights with respect
to the trade secrets, confidential and proprietary information or other intellectual property of the Company upon the Executive or any
third party; and (b) this arbitration provision shall not preclude the Company from seeking legal and equitable relief from any court
having jurisdiction with respect to any disputes or claims relating to or arising out of the misuse or misappropriation of the Company&rsquo;s
intellectual property. Judgment may be entered on the award of the arbitrator in any court having jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">8.2 <FONT STYLE="font-size: 10pt"><U>Costs
of Arbitration</U>. All costs of arbitration, including reasonable attorney&rsquo;s fees of the Executive, will be borne by the Company,
except that if the Executive initiates arbitration and the arbitrator finds the Executive&rsquo;s claims to be frivolous the Executive
shall be responsible for their own costs and attorneys&rsquo; fees. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">8.3 <FONT STYLE="font-size: 10pt"><U>Site
of Arbitration</U>. The site of the arbitration proceeding shall be in Austin, Texas.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-transform: uppercase">9. </FONT><FONT STYLE="font-size: 10pt"><U>NOTICES</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For purposes of this Agreement, notices and all
other communications provided for in the Agreement shall be in writing and shall be deemed to have been duly given when delivered or five
(5) business days after being mailed, return receipt requested, as follows: (a) if to the Company, attention: General Counsel, at the
Company&rsquo;s address at 1624 Market St. Ste 226, Unit 51767, Denver, Colorado 80202-1559 or legal@authid.ai and, (b) if to the Executive,
at the address indicated below or such other address specified by the Executive in writing to the Company. Either party may provide the
other with notices of change of address, which shall be effective upon receipt.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="text-transform: uppercase">10.&#9;</FONT><U>MISCELLANEOUS
PROVISIONS</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">10.1 <U>Heirs
and Representatives of the Executive; Successors and Assigns of the Company</U>. This Agreement shall be binding upon and shall inure
to the benefit of and be enforceable by the Executive&rsquo;s personal and legal representatives, executors, administrators, successors,
heirs, distributees, devises and legatees. This Agreement shall be binding upon and inure to the benefit of and be enforceable by the
successors and assigns of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">10.2 <U>Amendment
and Waiver</U>. No provision of this Agreement shall be modified, amended, waived or discharged unless the modification, amendment, waiver
or discharge is agreed to in writing, specifying such modification, amendment, waiver or discharge, and signed by the Executive and by
an authorized officer of the Company (other than the Executive). No waiver by either party of any breach of, or of compliance with, any
condition or provision of this Agreement by the other party shall be considered a waiver of any other condition or provision or of the
same condition or provision at another time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">10.3 <U>Withholding
Taxes</U>. All payments made under this Agreement shall be subject to deduction of all federal, state, local and other taxes required
to be withheld by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">10.4 <U>Severability</U>.
The invalidity or unenforceability of any provision or provisions of this Agreement shall not affect the validity or enforceability of
any other provision hereof, which shall remain in full force and effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">10.5 <U>Choice
of Law</U>. The validity, interpretation, construction and performance of this Agreement shall be governed by the laws of the State of
Illinois, without regard to where the Executive has their residence or principal office or where they perform their duties hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">10.6 <U>No
Duty to Mitigate</U>. The Executive is not required to seek alternative employment following termination, and payments called for under
this Agreement will not be reduced by earnings from any other source.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">10.7 <U>Section
409A of the Code</U>. The intent of the parties is that payments and benefits under this Agreement comply with Section 409A of the Code
and the Treasury Regulations and guidance promulgated thereunder (&ldquo;<B>Section 409A</B>&rdquo;), to the extent subject thereto, and
accordingly, to the maximum extent permitted, this letter shall be interpreted and administered to be in compliance therewith. Notwithstanding
anything contained herein to the contrary, Executive shall not be considered to have terminated employment with the Company for purposes
of any provision in this Agreement providing for the payment of any amounts or benefits subject to Section 409A upon or following a termination
of employment until Executive would be considered to have incurred a &ldquo;separation from service&rdquo; from the Company within the
meaning of Section 409A and this Agreement shall be interpreted consistently therewith. Without limiting the foregoing, and notwithstanding
anything to the contrary contained herein, to the extent (a) any payments or benefits to which Executive becomes entitled under this Agreement,
or under any agreement or plan referenced herein, in connection with Executive&rsquo;s termination of employment with the Company constitute
deferred compensation subject to Section 409A of the Code and (b) Executive is deemed at the time of such termination of employment to
be a &ldquo;specified employee&rdquo; under Section 409A of the Code, then such payments shall not be made or commence until the earliest
of (i) the expiration of the six (6)-month period measured from the date of Executive&rsquo;s &ldquo;separation from service&rdquo; (as
such term is at the time defined in Treasury Regulations under Section 409A of the Code) from the Company; or (ii) the date of Executive&rsquo;s
death following such separation from service; provided, however, that such deferral shall only be effected to the extent required to avoid
adverse tax treatment to Executive, including (without limitation) the additional twenty percent (20%) tax for which Executive would otherwise
be liable under Section 409A(a)(1)(B) of the Code in the absence of such deferral. Upon the expiration of the applicable deferral period,
any payments which would have otherwise been made during that period (whether in a single sum or in installments) in the absence of this
paragraph shall be paid to Executive or Executive&rsquo;s beneficiary in one lump sum (without interest). Any termination of Executive&rsquo;s
employment is intended to constitute a &ldquo;separation from service&rdquo; as such term is defined in Treasury Regulation Section 1.409A-1.
It is intended that each installment of the payments provided hereunder constitute separate and distinct &ldquo;payments&rdquo; for purposes
of Section 1.409A of the Code. It is further intended that payments hereunder satisfy, to the greatest extent possible, the exemption
from the application of Code Section 409A (and any state law of similar effect) provided under Treasury Regulation Section 1.409A-1(b)(4)
(as a &ldquo;short-term deferral&rdquo;). The Company makes no representation that any or all of the payments described or referenced
in this letter will be exempt from or comply with Section 409A and makes no undertaking to preclude Section 409A from applying to any
such payment, and Company&rsquo;s only obligation is to comply with its obligations set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">10.8 <U>Entire
Agreement</U>. This Agreement represents the entire agreement and understanding between the parties as to the subject matter herein (whether
oral or written and whether express or implied). The Executive hereby acknowledges, represents and warrants that they have been individually
represented by counsel in negotiating and signing this agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-variant: small-caps"><B><I>[SIGNATURE
PAGE FOLLOWS]<BR STYLE="clear: both">
</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-variant: small-caps"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-variant: small-caps">In Witness
Whereof</FONT>, each of the parties has executed this Agreement, in the case of the Company, by its duly authorized officer, as of the
day and year first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Executive</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ <B>RHONIEL A. DAGURO</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RHONIEL A. DAGURO</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">846 Farm Drive</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">West Chicago, IL 60185</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>authID Inc.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 36%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Thomas L. Thimot</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thomas L. Thimot, CEO</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>EXHIBIT 1</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>RELEASE OF CLAIMS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This General Release of all
Claims (this &ldquo;<U>Release</U>&rdquo;) is entered into on [&#9679;], by and between <B>AUTHID INC.</B>, a Delaware corporation (the
&ldquo;<U>Company</U>&rdquo;), and <B>RHONIEL A. DAGURO</B> (the &ldquo;<U>Executive</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In accordance with Section
7.3 of the Executive Retention Agreement by and between the Company and the Executive, effective __________, 2023 (the &ldquo;<U>Retention
Agreement</U>&rdquo;), in consideration of the payments and benefits to which the Executive is entitled pursuant to the Retention Agreement
subject to the execution and non-revocation of this Release, the Executive ag<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">rees
as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>General
                                            Release and Waiver of Claims</U>.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Release</I>.
                                            The Executive and each of the Executive&rsquo;s respective heirs, executors, administrators,
                                            representatives, agents, successors and assigns (collectively, the &ldquo;<U>Releasors</U>&rdquo;)
                                            hereby irrevocably and unconditionally release and forever discharge the Company and each
                                            of its subsidiaries and affiliates and each of their respective officers, employees, directors,
                                            managers, shareholders and agents (&ldquo;<U>Releasees</U>&rdquo;) from any and all claims,
                                            actions, causes of action, rights, judgments, obligations, damages, demands, accountings
                                            or liabilities of whatever kind or character (collectively, &ldquo;<U>Claims</U>&rdquo;),
                                            including, without limitation, any Claims under any federal, state, local or foreign law,
                                            that the Releasors may have or in the future may possess, arising out (i) of the Executive&rsquo;s
                                            employment relationship with and service as an employee, officer, manager or director of
                                            the Company, and the termination of such relationship or service and (ii) any event, condition,
                                            circumstance or obligation that occurred, existed or arose on or prior to the date hereof,
                                            physical injuries excepted; <I>provided, however</I>, that notwithstanding anything else
                                            herein to the contrary, this Release shall not affect: the obligations of the Company to
                                            pay the amounts due and owing to Executive on the Termination Date or other obligations that,
                                            in each case, by their terms, are to be performed after the date hereof by the Company; any
                                            indemnification or similar rights the Executive has as a current or former officer, manager
                                            or director of the Company, including, without limitation, any and all rights thereto referenced
                                            in the Company&rsquo;s governance documents or any rights with respect to &ldquo;directors&rsquo;
                                            and officers&rsquo;&rdquo; insurance policies; and the Executive&rsquo;s right to reimbursement
                                            of business expenses; any ownership Executive holds in Company Shares and other vested or
                                            acquired equity, and rights existing thereunder.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Specific
                                            Release of ADEA Claims</I>. The Releasors hereby unconditionally release and forever discharge
                                            the Releasees from any and all Claims that the Releasors may have as of the date the Executive
                                            signs this Release arising under the Federal Age Discrimination in Employment Act of 1967,
                                            as amended, and the applicable rules and regulations promulgated thereunder (&ldquo;<U>ADEA</U>&rdquo;).
                                            By signing this Release, the Executive hereby acknowledges and confirms the following: (i)&nbsp;the
                                            Executive was advised by the Company in connection with their termination to consult with
                                            an attorney of their choice prior to signing this Release and to have such attorney explain
                                            to the Executive the terms of this Release, including, without limitation, the terms relating
                                            to the Executive&rsquo;s release of claims arising under ADEA, and the Executive has in fact
                                            consulted with an attorney; (ii)&nbsp;the Executive was given a period of not fewer than
                                            twenty-one (21) calendar days to consider the terms of this Release and to consult with an
                                            attorney of their choosing with respect thereto; and (iii)&nbsp;the Executive knowingly and
                                            voluntarily accepts the terms of this Release. The Executive also understands that they have
                                            seven&nbsp;(7) calendar days following the date on which they sign this Release within which
                                            to revoke the release contained in this paragraph, by providing the Company a written notice
                                            of their revocation of the release and waiver contained in this paragraph.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Release
                                            of All Claims</I>. The Executive acknowledges, understands and agrees that they may later
                                            discover Claims or facts in addition to or different from those which they now knows or believes
                                            to be true with respect to the subject matters of this Release, but that it is nevertheless
                                            their intention by signing this Release to fully, finally and forever release any and all
                                            Claims whether now known or unknown, suspected or unsuspected, which now exist, may exist,
                                            or previously have existed as set forth herein.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive
                                            agrees and acknowledges that the released claims extend to and include unknown and unsuspected
                                            claims. In furtherance of the Executive&rsquo;s intent, the release in this Release shall
                                            remain in full and complete effect notwithstanding the discovery or existence of any additional,
                                            contrary, or different facts.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>No
                                            Assignment</I>. The Executive represents and warrants that they have not assigned any of
                                            the Claims being released under this Release.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Proceedings</U>.
                                            The Executive has not filed, and agrees not to initiate or cause to be initiated on their
                                            behalf, any complaint, charge, claim or proceeding against the Releasees before any local,
                                            state or federal agency, court or other body, other than in respect of any matter described
                                            in the proviso to Section 1(a) of this Release (each, individually, a &ldquo;<U>Proceeding</U>&rdquo;),
                                            and agrees not to participate voluntarily in any Proceeding. The Executive waives any right
                                            they have may have to benefit in any manner from any relief (whether monetary or otherwise)
                                            arising out of any Proceeding.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Remedies</U>.
                                            The Executive understands that by entering into this Release they have will be limiting the
                                            availability of certain remedies that they have may have against the Company and limiting
                                            also their ability to pursue certain claims against the Company.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Severability
                                            Clause</U>. In the event any provision or part of this Release is found to be invalid or
                                            unenforceable, only that particular provision or part so found, and not the entire Release,
                                            will be inoperative.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Non-admission</U>.
                                            Nothing contained in this Release will be deemed or construed as an admission of wrongdoing
                                            or liability on the part of the Company.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Governing
                                            Law</U>. All matters affecting this Release, including the validity thereof, are to be governed
                                            by, and interpreted and construed in accordance with, the laws of the State of Illinois applicable
                                            to contracts executed in and to be performed in that State.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Capitalized
                                            Te</U></FONT><U><FONT STYLE="font-family: Times New Roman, Times, Serif">rms</FONT></U><FONT STYLE="font-family: Times New Roman, Times, Serif">.
                                            Capitalized terms used but not defined herein have the meanings ascribed to them in the Retention
                                            Agreement.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>THE EXECUTIVE ACKNOWLEDGES THAT THEY HAVE READ
THIS RELEASE AND THAT THEY FULLY KNOW, UNDERSTAND AND APPRECIATE ITS CONTENTS, AND THAT THEY HEREBY EXECUTES THE SAME AND MAKES THIS AGREEMENT
AND THE RELEASE AND AGREEMENTS PROVIDED FOR HEREIN VOLUNTARILY AND OF THEIR OWN FREE WILL.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the Executive
has executed this Release on the date first set forth below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXECUTIVE:</B></FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RHONIAL A. DAGURO</B></FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ACKNOWLEDGED AND AGREED</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AUTHID INC.</B></FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify; width: 36%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Its:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">14</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>ea175837ex10-3_authid.htm
<DESCRIPTION>CONFIDENTIAL SEPARATION AGREEMENT AND GENERAL RELEASE BETWEEN THOMAS THIMOT AND AUTHID INC. DATED MARCH 23, 2023
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Exhibit 10.3</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.4pt 0 0">NOTE: Certain information indicated with [***] in this document
has been omitted from this exhibit because it is not material.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0.4pt 0 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>CONFIDENTIAL SEPARATION AGREEMENT AND
GENERAL RELEASE</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Confidential Separation
Agreement and General Release (&ldquo;Agreement&rdquo;) is made by and between <B>Thomas Thimot </B> (&ldquo;Employee&rdquo;) and <B>authID
Inc.</B> (&ldquo;the Company&rdquo;), (collectively, the &ldquo;Parties&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, Employee was
employed by the Company as Chief Executive Officer pursuant to an Offer Letter dated June 14, 2021 (&ldquo;Offer Letter&rdquo;) and entered
into an Executive Retention Agreement dated as of June 14, 2021 (&ldquo;Retention Agreement&rdquo;) which provides the Employee with certain
benefits upon Involuntary Termination (as defined in the Retention Agreement), as well as an Indemnification Agreement dated as of June
14, 2021 (&ldquo;Indemnification Agreement&rdquo;); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, the Parties
are entering into this Agreement for the purposes of separation of Employee from the Company as Chief Executive Officer and an employee
by mutual consent and settling, compromising and resolving all claims between them;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>NOW, THEREFORE</B>, in
consideration of the execution of this Agreement and for other good and valuable consideration, the Parties agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1. <B><U>Separation
of Employment.</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">The parties hereby agree that
Employee&rsquo;s employment is hereby terminated effective as of March 23, 2023 (&ldquo;Separation Date&rdquo;) and that neither party
shall thenceforth owe any duties or obligations to each other under the Offer Letter, (except to the extent of provisions expressly stated
to survive termination, as set forth in this Agreement) including but not limited to the obligation on the part of the Company to pay
to Employee any remuneration or other compensation for any period whether before or after the Separation Date, except as set forth in
this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2. <B><U>Final
Pay and Expenses</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) <U>Final
Pay</U> Company agrees to pay Employee his final accrued but unpaid salary for the period ending on the Separation Date as soon as practicable
and no later than the next payroll date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) <U>Expenses</U>
Within ten (10) days following submission to the Company of proper expense reports by you, the Company shall reimburse you for all expenses
incurred by you, consistent with the Company&rsquo;s expense reimbursement policy in effect prior to the incurring of each such expense,
in connection with the business of the Company prior to the Separation Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3. <B><U>Separation
Benefits.</U></B> In consideration for the release and other covenants in this Settlement Agreement, the Company shall provide the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) <U>Severance</U>
The Company agrees to make payment to Employee of an additional amount of $325,000 (less all applicable deductions required by law) (the
&ldquo;Severance Payment&rdquo;) subject to the following provisions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i) Payment
of the full amount of the Severance Payment shall be deferred until the earlier of (i) April 1, 2025; and (ii) a Change of Control of
the Company as defined below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii) The
Severance Payment shall be subordinated to the initial advance in the amount of $900,000 made pursuant to the Amended &amp; Restated Facility
Agreement entered into as of March 8, 2023 between the Company and Stephen Garchik, as well as to all present and future secured indebtedness
of the Company under the Senior Convertible Notes issued by the Company as of March 21, 2022 and pursuant to such Facility Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii) &ldquo;Change
of Control&rdquo; means:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(1) any
&ldquo;person&rdquo; (as such term is used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended (the &ldquo;<B><I>Exchange
Act</I></B>&rdquo;)) becomes the &ldquo;beneficial owner&rdquo; (as defined in Rule 13d-3 promulgated under the Exchange Act), directly
or indirectly, of securities of the Company representing fifty (50%) percent or more of (i) the outstanding shares of common stock of
the Company, or (ii) the combined voting power of the Company&rsquo;s outstanding securities;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(2) the
Company is party to a merger or consolidation, or series of related transactions, which results in the voting securities of the Company
outstanding immediately prior thereto failing to continue to represent (either by remaining outstanding or by being converted into voting
securities of the surviving entity), directly or indirectly, at least fifty (50%) percent of the combined voting power of the voting securities
of the Company or such surviving entity outstanding immediately after such merger or consolidation;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(3) the
sale or disposition of all or substantially all of the Company&rsquo;s assets, or consummation of any transaction, or series of related
transactions, having similar effect (other than to a subsidiary of the Company);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(4) a
change in the composition of the Board within any consecutive two-year period, as a result of which fewer than a majority of the directors
are Incumbent Directors. &ldquo;Incumbent Directors&rdquo; shall mean directors who either (i) were directors of the Company as of the
effective date of this Agreement, or (ii) are elected, or nominated for election, to the Board with the affirmative votes of a least a
majority of those directors whose election or nomination was not in connection with an actual or threatened proxy contest related to the
election of directors to the Company; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">(5) the
dissolution or liquidation of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) <U>COBRA</U>
As Employee is enrolled in certain Company healthcare plans, coverage will end on the last day of the month during which separation occurred,
namely March 31, 2023. Commencing April 1, 2023, Employee is eligible for continued medical coverage under the federal law known as COBRA.
Coverage may be purchased for such period as may permitted by law. Upon Employee&rsquo;s timely election to continue existing health benefits
under COBRA, and provided, however, that (i) Employee constitutes a qualified beneficiary, as defined in Section 4980(B)(g)(1) of the
Internal Revenue Code of 1986, as amended (the &ldquo;<B>Code</B>&rdquo;), and (ii) Employee elects continuation coverage within the time
period prescribed pursuant to COBRA, and consistent with the terms of COBRA and the Company&rsquo;s health insurance plan, the Company
will pay the insurance premiums to continue Employee&rsquo;s existing health benefits until the earlier of (1) March 31, 2024, (2) the
date Employee is eligible for health coverage for Employee and Employee&rsquo;s eligible dependents from a new employer or (3) the date
Employee and Employee&rsquo;s eligible dependents are no longer eligible for COBRA. Employee will thereafter be responsible for the payment
of premiums for any health insurance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> </P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Separation Agreement Thimot</P></TD><TD STYLE="text-align: center; width: 34%">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) <U>Equity.</U>
the Exercise Period with respect to vested Shares, under the Employees&rsquo;s stock options granted by the Company shall be extended
so as to expire four (4) years from the Separation Date date or the remaining term of the relevant equity award, whichever is the lesser.
All unvested Shares under any such grants or other equity awards shall lapse and no longer be exercisable as of the Separation Date. The
remaining vested options, which shall continue in force pursuant to this section are as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Date of Grant</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">No. of Shares</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Exercise Price</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Expiration Date</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 23%; text-align: center; padding-left: 5.4pt">14-Jun-2021</TD><TD STYLE="text-align: center; width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD><TD STYLE="width: 23%; text-align: center">262,500</TD><TD STYLE="width: 1%; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center"></TD><TD STYLE="width: 23%; text-align: center">$7.20</TD><TD STYLE="width: 1%; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; width: 1%">&nbsp;</TD>
    <TD STYLE="width: 23%; text-align: center; padding-left: 5.4pt">March 23, 2027</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d) <U>Indemnification</U>.
The terms of the Indemnification Agreement shall govern all claims related to actions arising prior to the Separation Date to the fullest
extent permitted by law and the Company shall continue to provide coverage under a D&amp;O Insurance Policy for not less than twenty-four
(24) months following the Separation Date on substantially the same terms as the D&amp;O Insurance Policy in effect immediately prior
to the Separation Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4. <B><U>Adequacy
of Consideration.</U></B> Employee understands and agrees that the sums that the Company has agreed to pay and the actions that it has
agreed to take or refrain from taking pursuant to this Agreement are a result of the Parties&rsquo; negotiations, have not been established
to be required of the Company in the absence of this Agreement, do not constitute an admission of liability, and constitute adequate and
reasonable consideration for the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5. <B><U>Proprietary
Information</U></B>: Employee hereby acknowledges that he is bound by the Employee Invention Assignment and Confidentiality
Agreement dated June 14, 2021 (the &ldquo;<B>Invention Assignment Agreement</B>&rdquo;) and that as a result of Employee&rsquo;s
employment with the Company Employee has had access to the Company&rsquo;s Confidential Information (as defined in the Invention
Assignment Agreement), that Employee will hold all Confidential Information in strictest confidence and that Employee will not make
use of such Confidential Information on behalf of anyone, other than the Company. The Invention Assignment Agreement shall remain in
full force and effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6. <B><U>Release
of Claims.</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) <I>Release</I>.
The Employee and each of the Employee&rsquo;s respective heirs, executors, administrators, representatives, agents, successors and assigns
(collectively, the &ldquo;<U>Releasors</U>&rdquo;) hereby irrevocably and unconditionally release and forever discharge the Company and
each of its subsidiaries and affiliates and each of their respective officers, employees, directors, managers, shareholders and agents
(&ldquo;<U>Releasees</U>&rdquo;) from any and all claims, actions, causes of action, rights, judgments, obligations, damages, demands,
accountings or liabilities of whatever kind or character (collectively, &ldquo;<U>Claims</U>&rdquo;), including, without limitation, any
Claims under any federal, state, local or foreign law, that the Releasors may have or in the future may possess, arising out (i) of the
Employee&rsquo;s employment relationship with and service as an employee, officer, manager or director of the Company, and the termination
of such relationship or service, including but not limited to the Offer Letter and the Retention Agreement and (ii) any event, condition,
circumstance or obligation that occurred, existed or arose on or prior to the date hereof; <I>provided, however</I>, that notwithstanding
anything else herein to the contrary, this Agreement shall not affect: (1) the obligations of the Company to pay the amounts due and owing
to Employee on the Separation Date or other obligations that, in each case, by the terms hereof, are to be performed after the date hereof
by the Company; (2) any indemnification or similar rights the Employee has pursuant to the Indemnification Agreement or as a current or
former officer, manager or director of the Company, including, without limitation, any and all rights thereto referenced in the Company&rsquo;s
governance documents or any rights with respect to &ldquo;directors&rsquo; and officers&rsquo;&rdquo; insurance policies; (3) the Employee&rsquo;s
right to reimbursement of proper and reasonable business expenses; and (4) Employee&rsquo;s rights as a stockholder of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) <I>Specific
Release of ADEA Claims</I>. The Releasors hereby unconditionally release and forever discharge the Releasees from any and all Claims that
the Releasors may have as of the date the Employee signs this Agreement arising under the Federal Age Discrimination in Employment Act
of 1967, as amended, and the applicable rules and regulations promulgated thereunder (&ldquo;<U>ADEA</U>&rdquo;). By signing this Agreement,
the Employee hereby acknowledges and confirms the following: (i)&nbsp;the Employee was advised by the Company in connection with his termination
to consult with an attorney of his choice prior to signing this Agreement and to have such attorney explain to the Employee the terms
of this Agreement, including, without limitation, the terms relating to the Employee&rsquo;s release of claims arising under ADEA, and
the Employee has in fact consulted with an attorney; (ii)&nbsp;the Employee was given a period of not fewer than forty-five (45) calendar
days to consider the terms of this Agreement and to consult with an attorney of his choosing with respect thereto; and (iii)&nbsp;the
Employee knowingly and voluntarily accepts the terms of this Agreement. The Employee also understands that he has seven&nbsp;(7) calendar
days following the date on which he signs this Agreement within which to revoke the release contained in this paragraph, by providing
the Company a written notice of his revocation of the release and waiver contained in this paragraph.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> </P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Separation Agreement Thimot</P></TD><TD STYLE="text-align: center; width: 34%">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) <I>Release
of All Claims</I>. The Employee acknowledges, understands and agrees that he may later discover Claims or facts in addition to or different
from those which he now knows or believes to be true with respect to the subject matters of this Agreement, but that it is nevertheless
his intention by signing this Agreement to fully, finally and forever release any and all Claims whether now known or unknown, suspected
or unsuspected, which now exist, may exist, or previously have existed as set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d) Employee
agrees and acknowledges that the released claims extend to and include unknown and unsuspected claims. In furtherance of the Employee&rsquo;s
intent, the release in this Agreement shall remain in full and complete effect notwithstanding the discovery or existence of any additional,
contrary, or different facts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e) <I>No
Assignment</I>. The Employee represents and warrants that he has not assigned any of the Claims being released under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f) <I>Proceedings</I>.
The Employee has not filed, and agrees not to initiate or cause to be initiated on his behalf, any complaint, charge, claim or proceeding
against the Releasees before any local, state or federal agency, court or other body, other than in respect of any matter described in
the proviso to Section 1(a) of this Agreement (each, individually, a &ldquo;<U>Proceeding</U>&rdquo;), and agrees not to participate voluntarily
in any Proceeding. The Employee waives any right he may have to benefit in any manner from any relief (whether monetary or otherwise)
arising out of any Proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g) <I>Remedies</I>.
The Executive understands that by entering into this Agreement he will be limiting the availability of certain remedies that he may have
against the Company and limiting also his ability to pursue certain claims against the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h) <I>Severability
Clause</I>. In the event any provision or part of this Agreement is found to be invalid or unenforceable, only that particular provision
or part so found, and not the entire Agreement, will be inoperative.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7. <B><U>APPLICABLE
ONLY TO CALIFORNIA RESIDENTS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><B><U>Waiver of Cal.
Civ. Code &sect; 1542</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) The
Parties acknowledge and agree that they may hereafter discover facts different from or in addition to those they now know or believe to
be true in respect to the claims released by this Agreement (&ldquo;Claims&rdquo;), and hereby agree that the releases contained herein
shall be and remain in effect in all respects as complete, general releases as to known and unknown Claims, notwithstanding any such different
or additional facts. In this regard, the Parties acknowledge that they are familiar with Section 1542 of the Civil Code of the State of
California (&ldquo;Section 1542&rdquo;) and that they waive and forever relinquish any right or benefit they may have under Section 1542,
which provides:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">A GENERAL RELEASE
DOES NOT EXTEND TO CLAIMS THAT THE CREDITOR OR RELEASING PARTY DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING
THE RELEASE, AND THAT IF KNOWN BY HIM OR HER WOULD HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR OR RELEASED PARTY.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Parties acknowledge that
they have been advised by legal counsel, or have had a full and fair opportunity to obtain such advice prior to executing this Agreement,
and that their waiver of Section 1542 is fully informed, voluntary, and an integral part of this Agreement. Notwithstanding the foregoing,
nothing contained in this Agreement shall release or relieve any Party from representations, warranties, covenants, obligations, undertakings
and agreements under this Agreement, which shall survive the execution and delivery of this Agreement, and for which each Party shall
remain fully liable and obligated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> </P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Separation Agreement Thimot</P></TD><TD STYLE="text-align: center; width: 34%">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8. <B><U>Confidentiality</U></B>
The Parties acknowledge that the terms of this Agreement, and the fact of this settlement, are strictly confidential, except to the extent
that the same are required to be disclosed pursuant to SEC rules and applicable law. Accordingly, the Parties agree not to disclose or
cause to be disclosed, either directly or indirectly, to any person or organization (other than their attorneys, spouses, accountants
or financial advisors) any information regarding the fact of, terms of, negotiations regarding this Agreement, except as provided above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9. <B><U>No
Admission of Liability</U></B>: This Agreement is not and shall not be construed or contended by either party to be an admission or evidence
of any wrongdoing or liability on the part of the Parties or the respective Releasees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">10. <B><U>Entire
Agreement, Modification and Severability.</U></B> This Agreement (including the Recitals) sets forth the entire agreement between the
Parties and fully supersedes any and all prior agreements or understandings, written or oral, between the Parties pertaining to its subject
matter, except as expressly noted or referenced herein and except for the Indemnification Agreement and the Invention Assignment Agreement
which shall continue in full force and effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">11. </FONT><B><U>Arbitration</U></B>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) <U>Disputes
Subject to Arbitration</U>. Any claim, dispute or controversy arising out of this Agreement (other than claims relating to misuse or misappropriation
of the intellectual property of the Company), the interpretation, validity or enforceability of this Agreement or the alleged breach thereof
shall be submitted by the parties to binding arbitration by a sole arbitrator under the rules&nbsp;of the American Arbitration Association;
provided, however, that (a)&nbsp;the arbitrator shall have no authority to make any ruling or judgment that would confer any rights with
respect to the trade secrets, confidential and proprietary information or other intellectual property of the Company upon Employee or
any third party; and (b)&nbsp;this arbitration provision shall not preclude the Company from seeking legal and equitable relief from any
court having jurisdiction with respect to any disputes or claims relating to or arising out of the misuse or misappropriation of the Company&rsquo;s
intellectual property. Judgment may be entered on the award of the arbitrator in any court having jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) <U>Costs
of Arbitration</U>. All costs of arbitration, including Employee&rsquo;s reasonable attorney&rsquo;s fees, will be borne by the Company,
except that if Employee initiates arbitration and the arbitrator finds wholly in favor of the Company, Employee shall be responsible for
his own costs and attorneys fees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) <U>Site
of Arbitration</U>. The site of the arbitration proceeding shall be in Santa Clara County, California.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">12. </FONT><B><U>Controlling
Law.</U></B> This Agreement shall be governed by and construed in accordance with the substantive and procedural laws of the State by
which Employee&rsquo;s Offer Letter was governed, without giving effect to principles of conflicts or choice of laws thereof. this Agreement
shall be interpreted as neutral as between the Parties, without regard to any presumptions, inferences or rules of construction based
on the authorship of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> </P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Separation Agreement Thimot</P></TD><TD STYLE="text-align: center; width: 34%">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">13. <B><U>Voluntary
Execution &amp; Revocation.</U></B> Employee explicitly and unconditionally acknowledges and agrees that they:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) have
carefully read and fully understand all of the terms of this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) understand
that by signing this Agreement, they are waiving their rights to all claims described in Paragraph 4 of this Agreement, including any
and all claims arising under the Age Discrimination in Employment Act of 1967 (29 U.S.C. &sect; 621 et seq.), and that they are not waiving
any rights arising after the date that this Agreement is signed;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) knowingly
and voluntarily agree to all of the terms set forth in this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d) knowingly
and voluntarily intend to be legally bound by this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e) are
receiving consideration (i.e. payment, resolution of a dispute without the risks and burdens of arbitration, a release, and a promise
of confidentiality) in addition to anything of value to which they are already entitled;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f) is hereby advised in
writing to consult with an attorney prior to signing this Agreement; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g) have
been given 45 days within which to consider this Agreement before signing it, and understand that the running of that 45-day period will
not be re-started by any changes to this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h) are
hereby advised that if the Older Workers Benefit Protection Act applies to Employee, (1) the attached Disclosure Schedule applies to this
Agreement and (2) they may revoke this Agreement in writing within 7 days of signing it (by submitting such written revocation to first
by e-mail: grahamarad@authid.ai and then by U.S. Mail Graham Arad &ndash; General Counsel, authID Inc., 1624 Market St. Ste 226, Unit
51767, Denver, Colorado 80202-1559, no later than the 8th day after signing), and that therefore, this Agreement shall not become effective
or enforceable, nor shall any consideration be paid, until this 7-day revocation period has expired (the &ldquo;Effective Date&rdquo;);
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i) have
not been coerced, threatened, or intimidated in any way into signing this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> </P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Separation Agreement Thimot</P></TD><TD STYLE="text-align: center; width: 34%">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">14. <B><U>Non-Disparagement:</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<B> </B>Employee
<FONT STYLE="background-color: white">agrees and covenants that they will not at any time make, publish or communicate to any person or
entity or in any public forum any defamatory or disparaging remarks, comments or statements concerning the Company or its businesses,
or any of its employees, directors officers, and existing and prospective customers, suppliers, investors and other associated third parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="background-color: white">(b)
 </FONT>Company <FONT STYLE="background-color: white">agrees and covenants that neither it, nor
any of its directors, officers or employees will at any time make, publish or communicate to any person or entity or in any public forum
any defamatory or disparaging remarks, comments or statements concerning Employee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">15. <B><U>Notices.</U></B>
All notices to be provided pursuant to this Agreement (and any consents permitted by the terms of this Agreement) shall be in writing
and delivered by hand or courier, or sent by e-mail transmission, or other electronic means, to their respective addresses as set forth
below to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD STYLE="text-align: justify; width: 0.75in">Employee:</TD>
                                                                <TD STYLE="text-align: justify">E-mail: tom.thimot@gmail.com</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(b)</TD><TD STYLE="text-align: justify; width: 0.75in">authID:</TD>
                                                                <TD STYLE="text-align: justify">1624 Market St. Ste 226, Unit 51767,</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0.25in">Denver, Colorado
80202-1559</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">Attn: General Counsel</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">E-mail: Legal@authid.ai</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All such notices delivered
by hand or by courier shall be deemed served upon receipt or refusal of receipt by the addressee. All notices given electronically shall
be deemed served upon the next business day after transmission, provided no error message was received.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">16. <B><U>Return
of Property.</U></B> You shall promptly return all property of Company and its subsidiaries&rsquo; (the &ldquo;Group&rdquo;) in your possession
or under your control, including but not limited to </FONT>all documents containing confidential, proprietary information and/or trade
secrets, customer and prospect lists, manuals, project plans, specifications or guidelines to me. In addition, and without prejudice to
the generality of the foregoing, you are requested to cooperate with the Company to transition all matters for which you have or had responsibility
to such Company personnel as the Company may require.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">17. <B><U>Employment
Verification</U></B>: All inquiries regarding your employment with the Company should be directed to Graham Arad &ndash; General Counsel,
authID Inc., 1624 Market St. Ste 226, Unit 51767, Denver, Colorado 80202-1559, telephone number &ndash; 516 274-8700, or email: grahamarad@authid.ai.
Reference inquiries will be responded to only by verifying dates of employment and last position held.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">18. <B><U>Future
Address &amp; Email Changes</U></B><U>:</U> As it may be necessary for the Company to reach you in the future, Company requests that you
notify the Company if you change your residence or email address. to Graham Arad &ndash; General Counsel, authID Inc., 1624 Market St.
Ste 226, Unit 51767, Denver, Colorado 80202-1559, telephone number &ndash; 516 274-8700, or email: grahamarad@authid.ai.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>THE EMPLOYEE ACKNOWLEDGES THAT HE HAS READ THIS RELEASE AND THAT
HE FULLY KNOWS, UNDERSTANDS AND APPRECIATES ITS CONTENTS, AND THAT HE HEREBY EXECUTES THE SAME AND MAKES THIS AGREEMENT AND THE RELEASE
AND AGREEMENTS PROVIDED FOR HEREIN VOLUNTARILY AND OF HIS OWN FREE WILL.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> </P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Separation Agreement Thimot</P></TD><TD STYLE="text-align: center; width: 34%">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, by signing
below, the Parties have executed this Confidential Separation Agreement and General Release, freely and voluntarily.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>THIS IS A LEGAL AGREEMENT AND RELEASE/WAIVER
OF CLAIMS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>READ CAREFULLY BEFORE SIGNING</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: justify"><FONT STYLE="font-size: 10pt"><U STYLE="text-decoration: none">/s/ Thomas Thimot</U></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Dated: <U>March 23, 2023</U></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 5%"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="text-align: justify; width: 35%">Thomas Thimot</TD>
    <TD STYLE="text-align: justify; width: 60%"></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">AUTHID INC.</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 35%"> <FONT STYLE="font-size: 10pt">/s/ Graham Arad</FONT></TD>
    <TD STYLE="text-align: center; width: 60%"><FONT STYLE="font-size: 10pt">Dated: <U>March 23, 2023</U></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Name:&nbsp; </FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Graham Arad</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">General Counsel</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> </P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Separation Agreement Thimot</P></TD><TD STYLE="text-align: center; width: 34%">&nbsp;<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Older
Workers Benefit Protection Act Disclosure Notice</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B></B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 4.95pt 3.25pt 0 3.05pt; text-align: center">[***]</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 33%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Form Settlement Agreement 02-08-2023</P>
</TD>
  <TD STYLE="text-align: center; width: 34%"></TD>
  <TD STYLE="width: 33%">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !' &@# 2(  A$! Q$!_\0
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MI'(55!))Z "HM9V9+T,GQ3J%QIGAN_O+4!IHHBR=\'UKYT36M3CNQJ*ZA/\
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>ex10-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex10-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !< *(# 2(  A$! Q$!_\0
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,\S*>LF%%%%9DG__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>ex10-1_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex10-1_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  ] '(# 2(  A$! Q$!_\0
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7[=.N(S7;UC-))6\_S(DEH%%%%9D'_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>auid-20230323.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: /qA5s7xRiXgen8uKa3EsWamMeaPtzplymZlBtmd2bVnKzygslNbyuyeF3nYmsWAA -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-gaap="http://fasb.org/srt-sup/2022q3" xmlns:srt="http://fasb.org/srt/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:AUID="http://authid.ai/20230323" elementFormDefault="qualified" targetNamespace="http://authid.ai/20230323">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://authid.ai/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="auid-20230323_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="auid-20230323_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
    <import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" />
    <import namespace="http://fasb.org/us-gaap-sup/2022q3" schemaLocation="https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd" />
    <import namespace="http://fasb.org/srt-sup/2022q3" schemaLocation="https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd" />
    <import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" />
    <import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" />
    <import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>auid-20230323_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>auid-20230323_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://authid.ai/role/Cover" xlink:href="auid-20230323.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://authid.ai/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139682163896352">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Mar. 23, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 23,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40747<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">authID Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001534154<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">46-2069547<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1385 S. Colorado Blvd.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Building A, Suite 322<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Denver<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CO<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">80222<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">516<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">274-8700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">AUID<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>ea175837-8k_authid_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="auid-20230323.xsd" xlink:type="simple"/>
    <context id="From2023-03-23to2023-03-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534154</identifier>
        </entity>
        <period>
            <startDate>2023-03-23</startDate>
            <endDate>2023-03-23</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2023-03-23to2023-03-23">0001534154</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2023-03-23to2023-03-23">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2023-03-23to2023-03-23">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2023-03-23to2023-03-23">2023-03-23</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2023-03-23to2023-03-23">authID Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2023-03-23to2023-03-23">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2023-03-23to2023-03-23">001-40747</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2023-03-23to2023-03-23">46-2069547</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2023-03-23to2023-03-23">1385 S. Colorado Blvd.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2023-03-23to2023-03-23">Building A, Suite 322</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2023-03-23to2023-03-23">Denver</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2023-03-23to2023-03-23">CO</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2023-03-23to2023-03-23">80222</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2023-03-23to2023-03-23">516</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2023-03-23to2023-03-23">274-8700</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2023-03-23to2023-03-23">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2023-03-23to2023-03-23">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2023-03-23to2023-03-23">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2023-03-23to2023-03-23">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2023-03-23to2023-03-23">Common Stock par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2023-03-23to2023-03-23">AUID</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2023-03-23to2023-03-23">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2023-03-23to2023-03-23">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="From2023-03-23to2023-03-23">true</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>13
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M/E"';P>'@9%I_KZ^D@;>_O/#D#-8M_8&N+Z6TKP/["> X@O.Z']02P,$%
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M$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:<Z10J[4+!XUA]) 1-MC0[!:+#Y
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M4')O<',O8V]R92YX;6Q02P$"% ,4    "  &0'Q6F5R<(Q &  "<)P  $P
M            @ ', 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    (
M  9 ?%9O^D[4BP0  ,T1   8              " @0T(  !X;"]W;W)K<VAE
M971S+W-H965T,2YX;6Q02P$"% ,4    "  &0'Q6GZ ;\+$"  #B#   #0
M            @ '.#   >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    (  9 ?%:7
MBKL<P    !,"   +              "  :H/  !?<F5L<R\N<F5L<U!+ 0(4
M Q0    (  9 ?%:JQ"(6,P$  "("   /              "  9,0  !X;"]W
M;W)K8F]O:RYX;6Q02P$"% ,4    "  &0'Q6)!Z;HJT   #X 0  &@
M        @ 'S$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4
M    "  &0'Q699!YDAD!  #/ P  $P              @ '8$@  6T-O;G1E
C;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"   B%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="ea175837-8k_authid.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://authid.ai/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="ea175837-8k_authid.htm">ea175837-8k_authid.htm</File>
    <File>auid-20230323.xsd</File>
    <File>auid-20230323_lab.xml</File>
    <File>auid-20230323_pre.xml</File>
    <File>ea175837ex10-1_authid.htm</File>
    <File>ea175837ex10-2_authid.htm</File>
    <File>ea175837ex10-3_authid.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>image_001.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "ea175837-8k_authid.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 24
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "ea175837-8k_authid.htm"
     ]
    },
    "labelLink": {
     "local": [
      "auid-20230323_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "auid-20230323_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "auid-20230323.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 24,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "AUID",
   "nsuri": "http://authid.ai/20230323",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "ea175837-8k_authid.htm",
      "contextRef": "From2023-03-23to2023-03-23",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://authid.ai/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "ea175837-8k_authid.htm",
      "contextRef": "From2023-03-23to2023-03-23",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://authid.ai/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://authid.ai/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://authid.ai/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://authid.ai/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://authid.ai/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://authid.ai/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://authid.ai/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://authid.ai/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://authid.ai/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://authid.ai/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://authid.ai/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://authid.ai/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://authid.ai/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://authid.ai/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://authid.ai/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://authid.ai/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://authid.ai/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://authid.ai/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://authid.ai/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://authid.ai/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://authid.ai/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://authid.ai/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://authid.ai/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://authid.ai/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://authid.ai/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://authid.ai/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://authid.ai/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://authid.ai/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://authid.ai/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://authid.ai/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://authid.ai/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://authid.ai/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://authid.ai/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://authid.ai/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://authid.ai/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://authid.ai/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://authid.ai/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://authid.ai/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://authid.ai/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://authid.ai/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://authid.ai/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://authid.ai/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://authid.ai/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://authid.ai/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://authid.ai/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://authid.ai/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://authid.ai/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://authid.ai/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://authid.ai/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://authid.ai/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://authid.ai/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://authid.ai/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://authid.ai/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://authid.ai/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://authid.ai/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://authid.ai/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://authid.ai/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://authid.ai/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001213900-23-023408-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-23-023408-xbrl.zip
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M.41<+L*UR@LH+5V\;^M3XOE3@[W+#4#V=HE2<GS2XR8,.6-CTK%-:FW*"YN
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M?D4OW92=543W\S!S=76KDM_>*I5^D@S/"BI__VM;5;;V/!AG, =1)); <9.
M;!N!< 20&M+UM=]>EK\&'L154S"((P9)#H2WA#I@4$&-,>3MVQ/29X8])GP@
M;AZ! 2;;^9/UM0$WD [< Z+XS-*9#K$Y\;@9&#ZUF!UXQI1X$*]Y@ZF8&DZP
M^P!9AG&V7#-1)@I@'9=0:QK=&]@&0,=Y:.4Y1J\>V? 8(\?,8BXU(#:T8'(@
M@G'2**@%B?#;W9<KMLY*2,F2T7Q)Z9\59+FU6)#%:^F#Y0?SI"6<Q@W,9\2E
M@EK%U9,3##;P5YK)+DECKUWN@P!A>A)8883O+:GT?W%.6EOMK^^OGQ_O)2O]
M?=LV&+5$(U/2.&6BA&*PLU6I["TU4(EL)#M;BGFP.JJ&J*(I2B)+G,#U E0I
M4$KL R 5M1JJ%^I5%WPSS.0 JZ'Y9$/9(LVC#@%"%V#@7%(H<JL5YE7_4Z@7
M4:CH8*)K&UP#WEK#4[#A8,B-;&TZ,\_.)V?,;OO;+ZI-B_C\FJHTPW-]S0PQ
M7=0CI4+SBII0I=9$&U%KR-**5"D5Y,C_Z=+OJ$M'H2Y=N R] #:7BL80#'3<
M\\%@69#\X:MSKUQ=G)7?:R^J4\OQ^C5U"_#-:PF$'_=72D7/JQO]MT_3-#GV
M?[KV.^I:,UO7VIX7,/=1C=.]+Y/&UO>SN_/GESB?H7$+V/TQ>E=F^<J&]C2]
M"\>^N-[M]V/56V$3 [C\61@LLU#F0AZ;I F,$)FE(FQ1F)4"'7;)BO/RWZQ1
M0=JB7[]7H8</G<D>-&U$-(-ZWM./B1\NR/P&1\<]EXIJ57=J]FWCOVCC9V$+
MDN ZB^P7Z/%XQ.'*3-F?>08-J@,;'+HV6$E4']O=)?]J-ENMHZ-7/YY>UD(9
M&K>IHO:%%F3[3V=Z_^FS]>5CV;E;05EW'B:>M)@FT+WKVR 0#G7)/34"1MZ4
M"OA,%''PX:G10XTV#\CKCPKIZ_(A:IX)E5#J8#832@=7DXN#1L5LK.) ( 4P
M5\<'67]_ZO; [RZM>(12%P4JRULQ3VFEO?WIVC"5YQ]BS!]"HGE9/'_,PBD'
M=LG3Z;=EIXY224ZI>\?\3?+Q8S,B]\OV.;S6&4/;TC'N9*0_)9HX;X!9=V"2
MF6BK29\%K*]QCP"W(6S%E8<$C.W8!Q=NFPX>$%"/Z&S +=E/*DN<I6H4H<W5
M-^&JLE,NDPW<Z-:>*'-&@[GH1'6P$Q5;?&00K/;S:KC6^EIBL50H+%>MQ*MB
M1#R;F%BW\ LV?F>RRN7#$>A::X[FS9#F#W>E1+..Q:1PSI+&C8\W7S0^/&GI
MZBJ3-M\-V.)Y>29>8;I66YZNK8QC+Y.\+-.QP0-*@P>8<RJ(I4[00;YP%#<"
M!6,&9#^@8)8M<J' 8V(4P T/_/"5'ESD1_+A8&2* &9,$?J8 VP4' NV!'=<
M=L\]F =J2RT-RZM4$^^A$#57?*&*3EW=DV=]^K),K+Q!XTPLJ8^%D,H/MDNV
M)KT8:?D(1[:$WKB3Z;FA*M_YUU>0T 6D7E$\5Y['_M2G:1-/RV8^39MXVO:G
M/TW[2K1'G/=@_+< JT"P[!XY=T3U9Q?7#?5JCWS"P!RR/[D_$=PMDGKNV>1D
M@I=DI:)F\+(FHN3%9[R3Q'?JT0/A"PBXC-[E^PRT"K!TQ*:2(&L9$!&-'P69
MY/DORNY'U"6\AG7;L%@L7 78?F:EKBS4'?OUML_,];5JH:220P;IFA^X(I$^
MY"[(B>UZ:,>;D!!3B+K.16.7Z^V1EA%:Y^30/=)P')M;/E8>\<[B//3&S/+P
MO0)3TABZ3%0IO<3@];5H]&NXS]<)A,\MDGY><),DGM\B&^C9L M)+>V%X8KX
M2]E[N[X&/I)T1K8%$DH:!7)(AX%KPWRBAV2/7&,S\ODB%0-G2@7A(=#^R'RX
MDG*NLBQRZD8+$HJ\D"T]S+UG&&XW1YP-P..&;7TQ8^8 8C@.'M(#!^[&?3[H
MD2WP;^CR+2N 'QXUJ"OZ?-Y42J7-4JE42,(?<\,@?8@U@'0<"Z$86< JX6P?
MJ,Q\,/%6X(GF^\!!7-^4MZJX%,$7A>E$QB7"#8/E(Y!X,L^W+>85L)%)(!W&
M+1#/8, BN5)6!%<J2%4!@5 3HQ2!; C &U&)H$.GHE ;.#;(:I(.5 ."W8LF
M*4MS9X+]1L$5Q"I *M_V83\84KCX[)RLCB#%8'D-!,8VL2-JIAD&-EIJ!AV+
M"I2'R8<0E /;O@-8WDQ2)$F09D.8/@R?Q7U334*/9DF">$'?$V[")_C@*PAU
M4B) \*+M"95%UHJ'"D":6"0$!S9$<))[9N #JXPIR"RBCR($^(1$CYDB.2EN
M 4A+\%FTH4E&"_JO+G_ZJ6K?2PB'H% 8YZ;E7H3,D;:LKPU%- [4M:7/CAG>
M#O7I..I91*XC&4&O(2B&6%W=K%1C:<7W7<$JFBS'>:+2('0J4@%D(+,DX\D]
M* I*+DC$5[ J(-AV*,\L,N9))J)LH)T <X"BK(M(%H2J)[(%YFH0]F-K,-R.
M%!MYK!FV)WO[\$XH02D,X1>\)LLFLCZROB8+)-$]R+1=D8H(#=8I*-[ 9[$0
M@>)J,<ZH5$ZHZW&+!T37>2?H&Q#9<RM^06&!7#DAA(AG?28Z/U';?3OB#)[%
MX'A8*.)0V,48;@$;SBW1!^T8*#?<#]6#WC&AG;,%%G@-5$_(AN#!MP#L/%$V
M%46P%M*F?\A;\AS6IGQ4(][!^EI*&C,%(&1SM,78D(+A0<-N/U\R2"P8TA#K
MH<GS C#J,R2EQA2(2)7U"*)(:H$8(^J'?Z>PGIV&SB^$+; C/I05+&JE)J^O
MS<].:>UF2KPD)70&8FER2VI([#F$C_#\^ 1R'@G(YR%AQC98H-HB_L)'+L G
M \A>LW:[# K2"QM\>9C@"RKS0?CZ-40B%LR4A!S&8V+16%]#V9C=6/2H_6F*
M/&E= &<2.>>D!YYM)*%%6)!P1>&!6YG[VEQ? V!C*L(1>S#P0(CHD.([7I=0
M1XA40DL3$A323OKUAV5?&I1H#$1H:&B% ()O >59(IE@3=P4Z32T<S[2CCJ.
MP67<AC3# )YK 41:,10I<WV(OE)$UZCKXD30^S%X<!EG)E8;!"(3B%;QEHD(
MJ)5%8%(@S"WZ?2$G-G))0D:>I07?I-/HG0"02J)$>2#UN.KZFBA!X7QI&U/Q
M2-)TEJNEASP=]00ME@KVAC27DFE8U]VLU)*N4^A/:L7E!F&%Y=Z?'JXP\2!F
MY!<2U,?B?.C(A%&@$.:A5Q>VB_I"F(4(HBAORK &2(P_[<"7I3$P:33PF/02
M<=1L>'8R98GS#=)AJ >BS3\*A^6Z,[0VXZ1&1"PRJTG%Y'%:$\5>L]=2>. !
MW=CG)0-_+W(45-- (%WT*[AJY$D!)2SWX]ML?8 Q%D5,88XB>@A9%E<HB0ZC
M!S+JMPTB4QMNW=L&0,.T*#%O$X57G&/C121\XMQ#!#D1-0IA3TH[=$+W4=2S
M&C32W!<OJ30D+2'Q9,@A5$F9*<7.'&MV" /I@TE9F/=M2@\-&4\<Y(OP'];K
M!_@<B$.Y'N<"#A:.;1B" 8S@A0C'Q"QA%L<T:SK87%Q 6M'$5D1@ !E/X.*Y
MTV9(D>2 YY(H*6I"-US&S3Z(9"K&C[85.71<G$.V(]F#Q&+4$%5[%,BAS'WG
M,C$A;U%NK#,,:D5ZF$SJF^<'G0;!\KHA!4*\ADGDZXI*Q"N.O,03-G-46E]#
M,LD]B4@J X,$8.K.)>L+F\!8@XJC !8^WDU"0BQ;/EH/4$D#LFQBV, :-PU2
M;/@/L;ZID_/%9A,P;>*U4S'1UM?PQ :)3=12&.ECH$(-!&R*R!BX#/QDVLB"
M18;334%HM!+HVC7J<!FR8-* <46!O&?B'*@?<,./ C]41WO 97N:9P]\?$V*
M6 FO,_&& <P$PJ0!)(R[)N2"IRCM:"DLWP#00AS4DK*-DHIOY]X$B9'%)EV4
M"E"51,6I@X8L8"11;NK:&J(LJF47,RVG?LI*C9@!@<P]=87MF#V/*FA"'-L+
M<QGA1"[P&P6>B+2Z4_AI M7>VZYO6V/;O?,DK<Y=JAFL$!["O(X@_+229,IO
MPN9[(UC<@Q_<M,&_1CZ:6^@88:0UD.\T!AGJ8NF8SOEJ7"-\:@]X:C#T!K&%
M#US@APS<O-GD,.:0(&?92HP5Q&5S5<E82J27B$R-R"9D04H4)R-\(-+W#:$6
M(DFP32[23KR%[ZPU1/E.E.(,RDV,V/TQ8\*_FH4$;M$SH^MK, TH*]$7;@FB
M=$U@EJ:O")2C #9R4M'&(%B. $/(X09IOQ:63D.5@R@&Q\:>1K;YBG@6ID.P
M)<Y59:*!A3LV%WVC@B?"(HC%$R1_4U9E&"Q#J3A=T/&5V\C]3._2 ,]K0 R]
MO@8[K4I69#G3P8*,@='W CQJ"H/(D"YQ[5B_%P%:%/G,RK([84W3I#I+.4'1
MP2'>7 [+_4U-9P^$3[PW0"='5.,&AFPS(4U+M9!'R;=MR;:D!*0P[_K,&<'U
M8QS-[T34-F;(0)$@ MVP&,!BR0L3*@][2P0\G?4!)RM\CCZY?/*Q/0N-'>B:
MZ$E$"WQF^Z V'-O1]?F4.8F_*HO:*@('3!(4$KGL(BF2XAT&^AB:S]?DM?!,
M)W3W?5!P< X+M3]9AQ*6%HC@R*1N?6U1@Z+RCA/I153R4FOJ9O6!#,\7ZKZ0
M;[_9*H _C-L,I4[&#0PC<*K#D2@ISG1SJT :L-W PO@>1HG44QQ\V:)1*1WG
MBWYI70IY.C21N @_26.F)JR;"$/_#/<1GAR2G4))(4=Q>X=X[X8\MT#ZM"8C
MW@?A>(V3O.RNFS^]J5X1'1*K[*0.>09VIO#4_G%E5>]7V]Y9]6X.F:>Y7-B6
M%79^N\/^AEJJ;*KE[4VU6GV;X&#TVS]O'E!*!47*\8H6E)T/C[[V:U4 E^DI
M)?*['XPJ6]7M\A:;**6\$GUY9^2#/H0'UC,O'3GAA8-P:8839^FZ</3"O,O-
MS5[12V<4^ >\OY:)V(Q<P"?UF6]3>X0H:HHH#Q?&5D:AE],,(%3YWR]#J7**
M4L]+32(*IM*>UZ7>@FRMSA8JI<K3W_RW0KA-4:$0?55M#+6IS(T.J4_E:PDW
MF-EG.@9G&"R&@7Y;?$:.X'?DB!Z^@/NQU_\M?DXD;)M:;)I::924J_^;X/<'
M]0"K#"@O48B,;ST7!8>H/YR%OG5$[U'>0-ALT4VAI\O8(K*JE90-^G:C^E:^
M8'T8&%*(N_F3/R6&?$+OHIK9N_A:'8N+3[@\J2,O5T]_P$QN9H_@9R9V2<.E
M?:Y%WS3##9_9N"$EU8D8S1+]LW]RE^3/$,'D!U_:QV>-WE5GQ1^8>2T=NDA7
M/B#7%LESW'N6?C9F?2WK>9;-K$<!P)I-Y7&=+FV7_(@#PNE#4@M8R'X[/,3M
MLQ$U!E$Q0E0OP@&0/;, *RMB.?2CM@O.07_!!V1^[8PO_3KC[/ '%D-']RZG
MKC@92GTS8%6O8@X)4RL]D@2&XZI/&U:>&_?C^*V0=/C%C]VHK+8=A7M9P=3J
M8!Y,=Q],O1]W=J&XSZP^WERE1!6]HGQ"K/X>3 H&S.0 B\87(VIFO03CQUGX
MPK&I\,"+CUR^!*@'*/1+DD8\S)TM@:M,#L19SJQ\&)[E_,'O^7X5(.JSG\A2
MLJ+%)S^1E5'8^^G/7#V)#47\)+!XD0U^?;K^Q \0;Q_<BH,%^9+2V8>+V8?)
MT==/I9/QU\;EJ%6\/)].JD=W2J]S;G[M7%U[[;O/+45MEEOF]/O-S45-FW;N
MZ?6X8U0^&>; ,$<'_,,954Z_7GZW.C?O#ULW@:J,:J-QP[[9NKP^;._XWM68
ME\<G_L1R/RO%@7=X.K9/#\POM:^!5FM^+"O]T?3Z1!O=V>:7GO&E>7I5LX;>
MP47GTW:Q_>G;3:M648-+W>L>WHW]XV*7?BY=-*]ZQ0]7]Q??OI6VVM^=@[-V
M9^OCY>?:X9U[W+S0R\JP^-5LGVY_;WTIU[C6I=^N@^+93?F[<MJ<3OA-*;A\
MO],O7AX<'TT^="_?O9,D^7]02P,$%     @ !D!\5JY4\971C   B7P# !D
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M)&U>I+#QY_6BU!)CO+?_>)KAA]C@V[?;X'7!:%'^9%:F\/8#LY5%\',%'X-
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M$& :N<@3@7(P?VC[B_6,.0X[S/&DW6<%[J,T+CZDQ &S:AFB7R^ 6<M3-$>
MP6-"%\+),"B]4T&C)4D!W _"81$$G>ZM9T$M;"]1"PM"+=S;ZBZ1"$LD0O#\
MZ2$1?@SNRKO;'</9[([=]'J[4\>6T32H T.1WKP%&?K>188^'AS@4CBL<)S/
M*!P(%F"?J6 KD!WT.@&\B:J[J =#QJS-OJ&.QI*'W@L2"L52>P#.-E,(P&T
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M@,CBLOT*@E2@-*\';E&=^HH&"XMBI"Y!L%GDB,3"7WV=T&NQ8CP\B"?'"-(
MM5B5GB2;H/UZ\%X-PJHP !0XBA"UH7>/TZPIY;. D#0C6!P>@5+3MQ;M5GAT
M$4=TQZI Q.>53,@%3@B&264/!(,X'U0C!$,.9+.9YE0IG-7&K@WBDN>0;0 \
MLU1ZCCXZ'6O=3IQ>9LDE@WKP1&(+P':ZPFYE<8U#1#=,\BIDOX=RU>]V"SV?
M>0M]PA02CAM[8M5.A#.&/94)BYSW4S^F;7O7^7FD5OS]@1;N7T$.S\ TU/'\
M"]X#59K$(R)8,:W*5/#I] @V#/A7$\K5:P]$=]F12LL+#-R&DP(E7RI'Z8!
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MH])U@):TNMX,;3)/6;7AM4+;"V82_2SO=@2_H]E4Z">%PG.(GF@8(XR?:<;
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M2&N/&(S>VY_PA^]<D9_/"YLI?K[1U%LS7[SU+1>W*,R9K]U^X5\\U[EY3,+
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M!Q+>9JFU\U9[G#;_)$_E6Y3J*R(",%VL*[I,,2"9V'[!OF$2D,;B/2EP%@)
MJP9D0YZ4<CSL*_ #P]PI^#2K$YI\O4(4W\#KT8AZCH)/MM*,2OZU/=[2X9A
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MN+<.1G@K-*UM,&*WU8?"=OSQKT>'_=V/!(_8_>7S\5'0O(%Y_?HMIEI[=\U
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MN<$ .-AXV*)O/KBH2A/=+5J[@#S_^>>?]1'91^6'W.;':%]5DEG@:H$7;K5
M"TX%?]K@Q61 #!HP_JN5TH:,HP9GJ@XU_9S&Y R42!02#%6$%"1NY""J9,+"
MTIT ZZ)Y.94"4;=86,W<2O \$UR*5!)?"G4HV6,]PU!EO])9%/9;=*"7PZGU
MP$>*K)"Y#IJY@^"6.6!RVG=UWNBFM<'Y=5TI^=A&\^4I\/;A%_R;J5 ' Z9"
MN%!N8$-F%-8'FXVQUY1D YAC:5C [0@T998SS'B$CBK9G"0<[E![,@U4G]8T
MRBGP#YN7N,4X!KV&MZ0.)SV3S>+B-S2T]0N!_8C^M8%EFP@[8I5PM-,F7&CX
M=3,&WE"-8=.N#+F@BRT\KY=20;7V95Q6!!\7H6_N+A%Z]'%3A3L0[=1"9/0:
MJ< ]7/A\9SS?6%7X==J@>^)QZ_X.)-]41JAS.-:>)N/IM95Y>Y5,>7MVL!!Q
MD\UC;I[C#PM4/'F69DEVCF3N_!#)&5Y(?0O=U^0\KI3)&"2\PN2$^W8_/24G
M@T@&)U1#>7P.'KUL("(D,#*INV;06\<YW-A[,.=+N%[O#6_M ;YG8DM?'#R\
MJ1/ [+ 79I#];N;"R(F>$)Z"6H"!0A>V@98@_?F.*_&Z6N>5=)Z*?XXRZ@B#
MYBCX(CK<XUVLWUH*$;L=>O75-SH_#J_I+;3VXR++:*L9DGJ-=[O=.LM]:(D-
MZ\FWK'%P\Q+K9[JK&]%6+J^R .M@1Z ::TN(>TU/I@R3',6(G%_*U=,OZY/+
MS9G ^UT#&0E98ZUCXZ>:7G+T,:HM>HUNQUD&BN0;SU5@ #I3CR=?FJ5K&-!F
M0L9(#141@/C,C*(Y5G0&%05&A:G(S[0BU]5ZII(F>>K@^&"S.X-(N' \#);
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MP?Q/"%:M4X^(^JM->3/OY CN='#4V4WO>'(T!GSKD\,)6CSDT?'D]^3@?LQ
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M'Y,=W]P&!<BM I[#OTRL'GY0(>X )N[@ZX!%R/!P;S^_ 5GK7E*/M*W",8>
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M?2?<-=F'8X59?YW&]#J)N5M+0>.%JXJJEU-B!DCJ* 1-C:-^+%(%T%(8SJM
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MML.?MBDMVB^5YK.G*:<>57 6CK,I*4\RU-B+DNL>\W/"F Z/;<"#$4=&&+6
M$A!B: 5>CJ%49CP^#!5C^8Z-ZN;)G]F\F3,Q84WE-JK-,_4V!XNUE\65(G?$
M=24C>CJS1;P?MN!&.S))<@XLD2G0"\>;&^&]2:$2GT)^^K.YK!;5VQX0EUO
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M3N*0%(\<RX+%6 98;^P:%4&A-@P,&6<'K#I8\F-F;%HHT -XG;$Z S"YE P
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M>HP5TFZ-PQ0&+KV8W9Y<+?&>K[:/ZXRLX\+-F-2II!B1*9DT39O!A\ ;PCO
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MJO^WSW /6)/H[&(?,^088KLWXRV7(1UH9.>%MQRK;B2NV^K_47W+%2 0A)6
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M/-9IO:+Z6M:<\:=A2NU.9BK;W5;^G19AP&F,<))%=.H9S%)^ZYHMCW??XA3
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M"H2AK$>SR>_).#.T5R$G1AGU=#D=S!<MB;&\4,!.2^X'U29N8!G<VL[V.B)
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M3,4X24)Z=.U'A3^,I*@,6,$HX>,@>/(C$#K)3?9\LTYAKX7R&;0K5V>P1(+
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M(WS*5A@MPS9M1=-?+$9OBBKL<NB^O 8X@SK%)#]PK4/+I:?^)U1"6-]S%0Y
M=6">?A@J/"EDW-.D8-WI/_?;A][N[J[8BI H$.C^;!8Q"Q:A#(N =;14_EDH
M3=B1?[,MMN!0F@VK(>KU@0$SK[A#@/W\@<2K*:OD2Z76]F,/]-X8."/2EMHV
M,"*+AH!21.Z9, >J 513Q! /!;1B/ EX746L"_MII(#2X&,<OP/,+!)[I,4?
MDJL&'L-S7QR#%!T30AS#3D&$PH^H%5:<#<;;-)1P5#^8]]T?M6GSW\SY'SL[
MXE3)*'P.)S"61S#PGP4:-/"JV-G1(:L7)[WW9G$\Y4Z>S."5]BPWB]@9)GF>
M3)^+)_ALF*3 ,NVS5Y$??,+)89T9"+P0EG!9'9$VX<+DQ6.8=<D"AJGT/^VP
M?? <& &NVEW4DR5KPH7>=4H'-(\1-@R.3<$0HJ0!\KXU- I<#\Y96]E68U$4
M!O'#:_I(.W,=7OS[[B[Q8HIPN%YP?*\#,P _%K_ZT]F1N))LX(I3/U"10JN[
M]#MI?S<[(EW+_IDV[!W_7DGXP"7ZN9R!U2Y>X]OJ4\6GC$.12);6K3@J\@),
MT4R"*D;3A7((:T+URO(V,WQIU?=EC*H6,"  7ZY0SIPG.1P5:*G%TD!!Z9E@
MGM:FV5T D>YG0'%O!NY/@)J FUHD,ZNG<]"\7LMD,97^#Q>Z]P::-@%F#YU5
M<ZNN@,V3);&!!T98"('0082.LB+C6$M?:N5G;W\K9'?7W@'^9(4T(+XBCU;W
M<\"BM1,0+>_]OG] Y.-KLMURXH6H7_=>FD^ <H/\Q>,>Z=5&;]K&<'DRU0$D
M_1T'C )D(LE-;(-<]1#150$DM;<?[NRCDC4MHC%QBI("W<5N>R($O2[((P /
MD"7&^_E7CV,4=HLU@@9;D5D!*G,C-0*ZVSK<_64;;?Z /'.IF)*GBI42\ID5
M.; M=@8 KTQY5-CG% R(+$] %-;T$0^'(9:+#^'-(>WR.J%I9\D-:SW+K,K*
M9'8;]X!]]X;U;8):LV&.#%";/+3$RX$-I&.$7DJ&'.H>VC4*3S*8EP\'S#D6
M8B#I,I_IP=-!3CB_(C)FG32'LA)E +^<(U'3J0P5C!U9XQL=U+"TD:\P6(6K
MA)7!F(7$GRW"B2WM;AZ2']4'P8IN &?LA/XVE/ASP'+&B$->9+.QN$IV$^,G
MB-3YW*$,42,,/Q=HY.;+\7[T95Q= -6"O,1#*,BK45V56 5#]@;3-RM.=I-0
M?U^C?N9'Y"L/539+,F4"=:C)$(2'"$M4RQ""^' Y+_&S3.:99T!:3*<V"$A>
M_I(XEI,/\+0*_4Q\.M),357DI\;!M<7^$G9U(HGB^A0<<#JO+6Q[D\[R $1O
MLZ%%EN8U&"EQSA,?O4K\E+/4X!T\%8J ZX!Y?I/LS,%,UAYI%LV:@>$ S-!&
M\L; '_BC_T>2$L7Q^$S^2:K#_;TX**9#)/@3\X>6L/D3"W\SLII-!%3!R@%A
M]D1HGH:B$A;A3%<7O+YYTFR4\3MTA"]&H$OI20D*F+TD0WH8)R8&B'X[^@O'
MH),:+-E&&8T4)01>$^MBU/8U#X2SJ8(JR61U;YFT,SASDUO6YTS )<Y:/(.
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MOM!R+XO0:;R3\ 4\3B%7I*TUJM#TD>^8-K7P>QJ+^.3?_56G>I=&/>?*8^G
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MHPO+RUY2:KG@7A3?V4__]!=02P$"% ,4    "  &0'Q6D];N6TP#  "P#
M$0              @ $     875I9"TR,#(S,#,R,RYX<V102P$"% ,4
M"  &0'Q6@/EG^OX*  " A@  %0              @ %[ P  875I9"TR,#(S
M,#,R,U]L86(N>&UL4$L! A0#%     @ !D!\5N1$Z-A5!P  SU<  !4
M         ( !K X  &%U:60M,C R,S S,C-?<')E+GAM;%!+ 0(4 Q0    (
M  9 ?%9G,ZH_6AH  !*    6              "  306  !E83$W-3@S-RTX
M:U]A=71H:60N:'1M4$L! A0#%     @ !D!\5JY4\971C   B7P# !D
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D &EM86=E7S P,2YJ<&=02P4&      @ "  9 @  .3$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
